Early onset COPD

COPD_EARLY

chronic obstructive pulmonary disease: A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Pre-conditions: EVENT_AGE<65 Registry filters: Hospital discharge: ICD-10 — J44 Hospital discharge: ICD-9 — 4912 Hospital discharge: ICD-8 — 49104 Cause of death: ICD-10 — J44 Cause of death: ICD-9 — 4912 Cause of death: ICD-8 — 49104 2 out of 7 registries used, show all original rules.	9785
4. Check minimum number of events None	9785
5. Include endpoints None	9785
6. Filter based on genotype QC (FinnGen only)	9785

Control definitions (FinnGen only)

Control exclude: COPD_EARLYANDLATER

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Alii morbi obstructivi chronici pulmonum

NAME	COPD_EARLY
CONTROL_EXCLUDE	COPD_EARLYANDLATER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS	EVENT_AGE<65
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J44
HD_ICD_9	4912
HD_ICD_8	49104
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J44
COD_ICD_9	4912
COD_ICD_8	49104
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Early onset COPD based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Early onset COPD, excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	81002	25780	53894
Only index persons	60251	21696	38555
Unadjusted period prevalence (%)
Whole population	1.26	0.74	1.51
Only index persons	1.23	0.80	1.47
Median age at first event (years)
Whole population	57.10	56.55	57.32
Only index persons	56.50	56.17	56.69

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9785	3696	6089
Unadjusted period prevalence (%)	2.15	1.26	2.68
Median age at first event (years)	57.24	56.02	57.98

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8555: Matched controls
85548

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C03CA01

ATC

furosemide; systemic

3.2

323.0

3432

14655

R96

ICPC

Asthma

4.9

323.0

1311

3053

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

7.0

323.0

1219

1975

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

323.0

508

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

13.6

323.0

4882

7635

R03BA01

ATC

beclometasone; inhalant

4.4

323.0

2110

5867

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

5.5

323.0

1561

3327

R03AC13

ATC

formoterol; inhalant

8.0

323.0

1055

1478

J45.8

ICD-10 Finland

Mixed asthma

9.8

323.0

699

773

J96.1

ICD-10 Finland

Chronic respiratory failure

29.0

323.0

781

295

J01MA14

ATC

moxifloxacin; systemic

4.2

323.0

1387

3737

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

13.3

323.0

723

589

R03DA04

ATC

theophylline; systemic, rectal

15.5

323.0

1652

1297

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.0

323.0

1542

3037

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

239.5

323.0

2817

175

J45

ICD-10 Finland

Asthma

4.5

323.0

1330

3393

R03AC12

ATC

salmeterol; inhalant

10.8

323.0

1145

1203

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

34.5

323.0

652

204

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

323.0

551

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

315.9

323.0

1838

H02AB06

ATC

prednisolone; systemic

5.7

323.0

6208

27122

R03AK06

ATC

salmeterol and fluticasone; inhalant

10.5

323.0

3424

5122

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

5.3

323.0

1824

4144

J01AA02

ATC

doxycycline; systemic

3.0

323.0

7182

54615

R03AC02

ATC

salbutamol; inhalant

8.4

323.0

6924

28758

R03BA05

ATC

fluticasone; inhalant

4.4

323.0

2577

7594

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

53.2

323.0

810

168

N07BA03

ATC

varenicline; oral

6.7

323.0

1008

1683

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

323.0

4763

26669

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

40.3

323.0

952

265

R03BA02

ATC

budesonide; inhalant

4.4

323.0

2504

7351

H02AB07

ATC

prednisone; oral

3.8

323.0

1991

6379

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

16.4

323.0

1748

1315

R06.0

ICD-10 Finland

Dyspnoea

4.0

323.0

3353

11794

R03AC03

ATC

terbutaline; inhalant

3.9

323.0

1864

5690

J45.9

ICD-10 Finland

Asthma, unspecified

8.3

323.0

3668

7089

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

38.1

323.0

590

166

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

639.3

323.0

7050

628

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.7

323.0

1327

2671

R03BB01

ATC

ipratropium bromide; inhalant

15.1

323.0

1169

888

R03AK07

ATC

formoterol and budesonide; inhalant

4.9

323.0

2941

8327

J45.1

ICD-10 Finland

Nonallergic asthma

8.1

323.0

1553

2287

R02

ICPC

Shortness of breath/dyspnoea

4.4

323.0

1706

4604

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.7

323.0

3720

11935

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.9

323.0

2415

7865

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

198.5

323.0

2706

199

R95

ICPC

Chron obstructive pulmonary disease

55.0

323.0

1332

286

R03BB04

ATC

tiotropium bromide; inhalant

37.6

323.0

4528

2483

J43.9

ICD-10 Finland

Emphysema, unspecified

22.9

323.0

501

232

R03DC03

ATC

montelukast; oral

3.5

323.0

1913

6516

J46

ICD-10 Finland

Status asthmaticus

10.8

309.3

622

617

XG410

NOMESCO Finland

Flow-volume spirometry

6.8

305.2

826

1330

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

302.9

289

J01FA06

ATC

roxithromycin; oral

2.3

282.8

3965

23188

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.0

279.5

1966

7800

J01MA12

ATC

levofloxacin; systemic

2.7

263.8

2202

9679

I50.9

ICD-10 Finland

Heart failure, unspecified

3.3

260.4

1552

5457

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.3

259.1

486

416

H02AB04

ATC

methylprednisolone; systemic

3.0

256.8

1732

6635

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

255.9

4612

29802

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

37.5

249.3

322

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.2

249.0

843

1777

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.0

241.0

1056

2880

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

22.8

237.3

350

160

R03AC18

ATC

indacaterol; inhalant

35.1

230.4

302

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.6

228.7

864

2039

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

7.3

227.8

577

836

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.8

218.9

1041

3035

348

Kela drug reimbursment

Roflumilast

1956.0

208.0

201

Z72.0

ICD-10 Finland

Tobacco use

7.5

205.3

512

723

N05AA02

ATC

levomepromazine; systemic

5.1

205.0

699

1474

N05BA01

ATC

diazepam; systemic, rectal

2.8

199.5

1513

6143

C07AB07

ATC

bisoprolol; oral

2.0

197.0

4417

29889

N02AX02

ATC

tramadol; systemic, rectal

2.0

196.9

4040

26409

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

23.7

196.0

285

124

N06AB04

ATC

citalopram; systemic

2.4

193.3

2106

10422

R03AK08

ATC

formoterol and beclometasone; inhalant

5.7

186.4

574

1073

N05CD07

ATC

temazepam; oral

2.7

185.2

1429

5838

R03DX07

ATC

roflumilast; oral

1931.2

184.9

179

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

183.5

1630

7222

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.1

183.0

618

1285

N05AH04

ATC

quetiapine; oral

2.6

183.0

1568

6805

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.5

182.7

928

2834

N05CF01

ATC

zopiclone; oral

2.0

177.6

2993

17869

R06.2

ICD-10 Finland

Wheezing

4.9

176.0

616

1331

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

5.1

175.0

589

1219

XG466

NOMESCO Finland

Sleep oxymetry

5.2

174.8

575

1160

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.1

173.2

1089

3888

N05BA04

ATC

oxazepam; oral

2.2

171.6

2246

12010

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

46.0

167.5

207

GD1AD

NOMESCO Finland

Thorax CT examination

4.4

166.2

651

1576

R04.2

ICD-10 Finland

Haemoptysis

5.1

164.5

555

1150

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.1

161.9

987

3439

G47.3

ICD-10 Finland

Sleep apnoea

2.1

156.3

2283

12708

SPAT1059

SPAT

Spirometry at the office

3.9

154.8

687

1863

J20

ICD-10 Finland

Acute bronchitis

3.0

153.9

1009

3686

A02BC02

ATC

pantoprazole; systemic

1.8

151.3

5552

42871

SPAT1254

SPAT

Administration of medicine

2.5

150.8

1394

6240

R03BB07

ATC

umeclidinium bromide; inhalant

20.2

146.0

223

113

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.1

144.5

481

979

A06AD11

ATC

lactulose; oral

2.4

143.2

1425

6609

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.3

141.9

456

892

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

19.7

140.8

217

113

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

140.1

1071

4295

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.0

139.7

2295

13283

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

139.6

1664

8412

J01DA01

ATC

[U] cefalexin; systemic

1.8

138.4

5282

40665

J01FF01

ATC

clindamycin; systemic

1.9

136.4

2487

14952

I50.0

ICD-10 Finland

Congestive heart failure

3.2

135.9

787

2628

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.1

135.6

575

1493

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

135.5

2617

16062

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.2

134.3

441

883

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

12.8

133.9

245

197

N06AX11

ATC

mirtazapine; oral

1.9

132.3

2659

16522

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

11.8

132.0

251

219

R03BA08

ATC

ciclesonide; inhalant

3.0

131.6

847

3038

EBA00

NOMESCO Finland

Extraction of tooth

1.8

130.5

2849

18196

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.3

128.6

414

810

R03BB02

ATC

oxitropium bromide; inhalant

20.3

128.1

195

J96.0

ICD-10 Finland

Acute respiratory failure

10.1

128.1

263

267

N07BB01

ATC

disulfiram; oral

3.7

127.6

612

1765

C03DA01

ATC

spironolactone; oral

2.5

125.6

1095

4712

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.8

123.8

326

494

K05.31

ICD-10 Finland

Periodontitis pronounced

2.5

123.6

1103

4805

R03AK11

ATC

formoterol and fluticasone; inhalant

5.7

121.6

367

665

A01AB09

ATC

miconazole; local oral

2.8

120.9

866

3321

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

120.6

2248

13504

N05AH03

ATC

olanzapine; systemic

3.4

120.4

625

1918

WX722

NOMESCO Finland

PEEP

3.4

118.3

632

1982

N05AF03

ATC

chlorprothixene; systemic

5.0

117.8

403

843

A07AA02

ATC

nystatin; oral

3.2

114.9

667

2222

E66.01

ICD-10 Finland

Obesity due to excess calories

2.9

113.2

753

2750

A46

ICD-10 Finland

Erysipelas

2.2

112.8

1389

7050

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

111.5

1894

10944

N03AX16

ATC

pregabalin; oral

1.9

110.0

2061

12331

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.6

109.3

535

1565

A02BC01

ATC

omeprazole; systemic

1.8

108.5

2392

15115

J01CA04

ATC

amoxicillin; systemic

1.7

108.2

6436

54310

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.8

107.6

318

561

WX892

NOMESCO Finland

Monitored bed care

2.6

106.5

830

3336

C01AA05

ATC

digoxin; systemic

2.7

105.3

793

3123

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

7.6

105.0

256

347

J47

ICD-10 Finland

Bronchiectasis

6.6

104.5

281

438

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

5.3

104.1

334

650

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

103.7

1051

4856

N02AA05

ATC

oxycodone; systemic

2.1

102.3

1355

7066

P17

ICPC

Tobacco abuse

7.9

100.6

239

311

N03AG01

ATC

valproic acid; systemic, rectal

3.0

100.6

630

2204

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

100.5

1080

5128

J42

ICD-10 Finland

Unspecified chronic bronchitis

8.3

100.3

230

283

R05

ICPC

Cough

1.9

99.7

1773

10359

N05BA02

ATC

chlordiazepoxide; systemic

4.4

99.3

382

901

XG405

NOMESCO Finland

Education on PEF monitoring

6.9

98.9

258

386

XG460

NOMESCO Finland

Short time oxymetry

6.7

98.0

260

398

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

98.0

1739

10142

R60.0

ICD-10 Finland

Localized oedema

2.3

97.9

1001

4637

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

97.5

2706

18239

N06AB03

ATC

fluoxetine; oral

2.2

97.1

1110

5418

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

96.7

2464

16180

WX725

NOMESCO Finland

Noninvasive ventilation

3.3

96.6

527

1673

A02BA02

ATC

ranitidine; systemic

1.9

96.2

1753

10310

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

96.2

1108

5426

R03AC19

ATC

olodaterol; inhalant

29.3

95.4

130

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

94.7

2061

12863

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.0

94.4

318

653

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.6

94.2

348

788

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.4

94.2

498

1544

R05FB02

ATC

cough suppressants and expectorants

1.6

93.3

3099

21905

N06AX16

ATC

venlafaxine; oral

2.2

93.2

1116

5554

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

92.8

2317

15080

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

92.0

2914

20311

C01DA14

ATC

isosorbide mononitrate; oral

2.0

90.7

1363

7447

R05CB01

ATC

acetylcysteine; inhalant, oral

6.6

90.6

242

374

J01FA09

ATC

clarithromycin; systemic

1.7

89.3

2505

16831

A10BA02

ATC

metformin; oral

1.7

89.2

2501

16803

J37.0

ICD-10 Finland

Chronic laryngitis

4.0

88.1

375

971

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

8.8

86.2

190

219

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.5

85.4

432

1293

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

85.1

608

2310

N06AA12

ATC

doxepin; systemic

2.9

84.7

561

2033

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

84.5

1428

8129

A28

ICPC

Limited function/disability NOS

2.0

84.4

1189

6315

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

83.9

1576

9311

N05AA01

ATC

chlorpromazine; systemic, rectal

6.3

83.5

232

378

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

83.5

654

2621

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

83.3

2424

16391

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

83.3

1992

12721

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

82.9

275

555

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.2

82.8

925

4446

R03BB06

ATC

glycopyrronium bromide; inhalant

21.5

82.7

123

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

82.2

670

2747

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

4.6

81.7

295

652

N05AD01

ATC

haloperidol; systemic

3.8

81.6

364

982

V03AA01

ATC

4.7

81.1

290

635

N05AB03

ATC

perphenazine; systemic, rectal

3.5

80.5

402

1191

T90

ICPC

Diabetes non-insulin dependent

1.7

80.2

2076

13547

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

80.2

425

1318

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

49.0

79.8

SPAT1263

SPAT

Sampling

1.6

79.5

3260

24039

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

79.3

2030

13197

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

78.9

1961

12634

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

78.6

1207

6614

N05BA06

ATC

lorazepam; systemic, sublingual

2.9

77.6

509

1829

A02BC03

ATC

lansoprazole; oral

1.6

77.5

2426

16666

J01DB01

ATC

cefalexin; oral

1.6

77.3

6567

57398

TGC00

NOMESCO Finland

Bronchial lavation

3.9

76.5

332

874

SPAT1058

SPAT

PEF monitoring instruction

2.4

76.1

732

3271

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

4.0

76.0

325

845

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.8

76.0

531

1987

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

75.7

992

5099

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.1

75.2

310

780

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

74.7

1145

6262

N05AX08

ATC

risperidone; systemic

2.4

74.6

671

2896

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

74.3

957

4881

N05AC02

ATC

thioridazine; oral

4.7

73.8

262

569

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

73.7

908

4544

P01AB01

ATC

metronidazole; oral, rectal

1.6

73.6

2979

21776

N05AH02

ATC

clozapine; systemic

5.2

73.5

238

468

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

73.5

560

2205

R06AE07

ATC

cetirizine; oral

1.6

73.4

3143

23287

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.8

72.6

253

539

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

72.4

1730

10970

F10.24

ICD-10 Finland

Alcohol depence active use

5.4

71.7

225

427

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.5

71.4

355

1047

XQ800

NOMESCO Finland

Prick test

2.5

71.1

588

2421

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.8

70.9

248

531

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

70.6

2139

14495

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

70.3

375

1167

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

4.4

69.8

266

621

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

69.6

1829

11907

P15

ICPC

Chronic alcohol abuse

3.5

69.3

340

992

N06AA09

ATC

amitriptyline; systemic

2.1

69.0

868

4376

E66.9

ICD-10 Finland

Obesity, unspecified

3.5

68.5

343

1017

M05BA04

ATC

alendronic acid; oral

2.4

68.5

605

2583

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

67.5

2280

15858

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

67.1

2302

16066

B01AC04

ATC

clopidogrel; oral

1.8

67.1

1384

8366

R81

ICPC

Pneumonia

3.4

66.8

342

1032

J01FA15

ATC

telithromycin; oral

2.0

65.8

889

4613

N05AX12

ATC

aripiprazole; systemic

3.7

65.7

305

851

N04AA02

ATC

biperiden; systemic

4.3

65.6

254

602

N06AX03

ATC

mianserin; oral

2.7

65.6

477

1825

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.6

64.9

2100

14420

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

64.7

2267

15880

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

63.8

1192

6963

A01AB04

ATC

amphotericin B; local oral

2.7

63.6

450

1693

N03AX12

ATC

gabapentin; oral

1.8

63.1

1244

7396

E66.8

ICD-10 Finland

Other obesity

2.8

62.8

441

1652

S97

ICPC

Chronic ulcer skin

2.6

62.7

507

2059

R03BB05

ATC

aclidinium bromide; inhalant

28.0

62.7

R28

ICPC

Limited function/disability (R)

6.1

62.5

176

293

N06AB06

ATC

sertraline; oral

2.1

62.4

795

4024

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

9.0

62.3

135

152

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

61.8

2095

14526

S10

ICPC

Boil/carbuncle

2.6

61.7

485

1940

K08.3

ICD-10 Finland

Retained dental root

2.2

61.5

661

3101

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.7

61.1

182

325

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.3

61.0

237

564

A02BA04

ATC

nizatidine; systemic

2.2

60.8

706

3433

XF600

NOMESCO Finland

Bloodpressure measurement

2.4

60.7

567

2488

R4110

NOMESCO Finland

Physiotherapy

1.6

60.6

2107

14682

N06AB10

ATC

escitalopram; oral

1.7

60.5

1354

8363

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

6.5

60.5

163

256

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

60.3

673

3213

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

60.3

3093

23558

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

59.7

973

5412

SPAT1262

SPAT

Handing over of treatment supplies

1.7

59.6

1555

10042

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.4

59.6

304

915

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

59.5

1034

5880

R03DC01

ATC

zafirlukast; oral

4.8

59.3

204

429

R29

ICPC

Respiratory symptom/complaint other

2.4

59.3

523

2225

N05AB01

ATC

dixyrazine; systemic

4.9

59.2

201

417

AN1

Coronary angiography

1.8

59.2

1074

6198

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

8.4

59.0

133

160

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

58.9

2159

15221

A98

ICPC

Health maint/preventive medicine

0.6

58.8

6826

73986

SPAT1240

SPAT

Therapeutic discussion

2.1

58.7

707

3488

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.0

58.7

355

1206

49300

ICD-8 Finland

Asthma, bronchiale

3.7

58.6

266

728

J43.8

ICD-10 Finland

Other emphysema

25.8

58.5

N06AX21

ATC

duloxetine; oral

2.0

58.5

827

4357

M54.5

ICD-10 Finland

Low back pain

1.5

58.3

2368

17096

N05BE01

ATC

buspirone; oral

3.3

58.3

315

990

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

5.9

57.7

166

284

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

57.2

622

2934

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

57.2

3599

28497

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.0

57.1

163

276

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

56.4

817

4345

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.2

56.0

597

2788

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

55.3

1175

7124

E0000UV

ATC

1.5

55.1

2801

21179

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

55.0

379

1402

J96.9

ICD-10 Finland

Respiratory failure, unspecified

10.1

54.8

111

J01DA06

ATC

[U] cefuroxime; systemic

1.8

54.8

1165

7064

J43.2

ICD-10 Finland

Centrilobular emphysema

20.7

54.7

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

3.4

54.5

273

810

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.4

54.4

505

2205

N05AF05

ATC

zuclopenthixol; systemic

5.7

54.2

161

287

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.7

54.2

245

669

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

5.6

54.0

162

292

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

10.3

53.9

108

106

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

4.0

53.6

223

566

L28

ICPC

Limited function/disability (L)

1.7

53.3

1142

6940

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

53.1

1427

9258

R78

ICPC

Acute bronchitis/bronchiolitis

3.9

52.7

230

609

B01AA03

ATC

warfarin; systemic

1.6

52.7

1614

10836

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

52.6

597

2866

M79.6

ICD-10 Finland

Pain in limb

1.5

52.6

2573

19254

WX730

NOMESCO Finland

Conventional respirator

4.4

52.5

200

468

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.8

52.4

153

267

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

7.3

52.3

129

179

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

8.4

52.0

117

141

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.2

51.7

165

320

AA1AD

NOMESCO Finland

CT of head and brain

1.6

51.6

1847

12879

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

5.4

51.4

159

298

I50.1

ICD-10 Finland

Left ventricular failure

2.5

51.3

434

1806

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

51.2

454

1937

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

7.1

51.2

129

185

E000001

ATC

1.6

51.2

1470

9698

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

51.2

893

5070

N02BE01

ATC

paracetamol; systemic, rectal

1.5

51.0

6823

61860

N03AF01

ATC

carbamazepine; oral, rectal

2.4

50.9

477

2090

R53

ICD-10 Finland

Malaise and fatigue

1.6

50.5

1374

8932

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.5

50.4

135

211

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.7

50.1

178

388

J98.1

ICD-10 Finland

Pulmonary collapse

8.4

49.5

111

133

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

8.2

49.4

113

140

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

5.2

49.2

159

313

N05BA12

ATC

alprazolam; oral

1.9

49.2

807

4479

J43

ICD-10 Finland

Emphysema

46.4

49.1

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.0

49.1

164

335

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

49.0

1099

6756

A03

ICPC

Fever

1.8

48.8

1004

6011

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

48.7

237

688

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

48.5

490

2227

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

48.4

361

1399

P72

ICPC

Schizophrenia

4.2

48.3

192

468

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

6.0

48.3

137

231

N06AX12

ATC

bupropion; oral

2.4

48.2

416

1749

P99

ICPC

Psychological disorders other

3.6

48.0

228

649

P29

ICPC

Psychological sympt/compl other

2.6

47.9

374

1489

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

47.7

378

1517

N03AX09

ATC

lamotrigine; oral

2.7

47.6

338

1272

N05AN01

ATC

lithium; oral

3.4

47.5

237

702

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

5.0

47.2

156

315

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

25.6

47.1

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

5.8

46.7

136

237

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.0

46.5

290

1005

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

46.2

1540

10515

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.7

46.2

162

349

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.3

46.1

474

2172

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

46.0

1968

25897

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

46.0

868

5048

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

45.8

706

3830

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.3

45.7

143

272

R50.9

ICD-10 Finland

Fever, unspecified

1.7

45.3

1051

6515

A10AE04

ATC

insulin glargine; parenteral

1.8

45.2

789

4470

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.8

45.2

156

331

WX882

NOMESCO Finland

High dependency care

3.0

45.1

273

929

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

44.9

309

1142

1240

FHL

Bronchoscopy

5.1

44.8

147

295

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

11.1

44.8

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

5.1

44.8

146

291

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

44.7

388

1636

A01

ICPC

Pain general/multiple sites

2.1

44.6

558

2789

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

44.6

459

2104

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

44.5

334

1300

WX110

NOMESCO Finland

Local anesthesy

1.4

44.2

5122

44419

A02BC05

ATC

esomeprazole; systemic

1.4

44.1

3034

24044

R11

ICD-10 Finland

Nausea and vomiting

2.1

44.1

536

2646

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

43.8

1363

9141

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.0

43.7

110

158

S22.3

ICD-10 Finland

Fracture of rib

2.0

43.7

566

2869

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

43.6

786

4502

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

5.2

43.5

140

275

ZX120

NOMESCO Finland

Intravenous

1.8

43.2

746

4208

SPAT1301

SPAT

No procedures

1.4

43.2

2274

17122

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

15.1

43.1

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

42.9

1008

6262

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

42.8

399

1745

L17

ICPC

Foot/toe symptom/complaint

1.5

42.5

1779

12770

P01

ICPC

Feeling anxious/nervous/tense

2.1

42.3

514

2539

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

4.8

42.1

144

303

Z72.1

ICD-10 Finland

Alcohol use

4.3

42.0

159

371

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

41.9

398

1756

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

5.0

41.9

139

283

WZC30

NOMESCO Finland

Teaching

1.7

41.9

1054

6675

SPAT1255

SPAT

Intravenous administration of medicine

2.0

41.8

539

2725

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

41.8

2407

18413

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.0

41.7

138

280

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

41.4

742

4238

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.5

41.4

199

573

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

41.1

1094

7033

R63.4

ICD-10 Finland

Abnormal weight loss

2.7

41.1

292

1102

R04

ICPC

Breathing problem other

2.7

41.0

296

1128

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

12.2

40.9

WW200

NOMESCO Finland

Immunization

2.9

40.9

261

921

M04AA01

ATC

allopurinol; systemic

1.6

40.9

1098

7073

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.8

40.9

178

472

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

40.6

2950

23509

EBA30

NOMESCO Finland

Excision of root of tooth

2.1

40.4

482

2362

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

40.1

1921

14151

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

6.4

40.1

108

171

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

39.9

311

1237

C09AA05

ATC

ramipril; oral

1.5

39.9

1958

14491

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

39.8

2731

21525

A04

ICPC

Weakness/tiredness general

1.8

39.8

811

4824

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.7

39.5

177

481

F61.0

ICD-10 Finland

Mixed personality disorders

3.9

39.5

166

427

D07AC01

ATC

betamethasone; topical

1.4

39.5

2502

19435

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.1

39.4

488

2427

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

39.3

518

2645

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.8

39.1

170

451

SPAT1060

SPAT

Administration of oxygen

9.5

38.9

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

38.9

811

4855

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.9

38.8

131

272

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

4.4

38.8

146

339

R51.80

ICD-10 Finland

Headache

1.7

38.8

912

5660

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

5.6

38.8

116

210

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

38.8

516

2643

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.7

38.7

278

1056

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

38.4

1156

7662

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

38.2

608

3331

WX872

NOMESCO Finland

Intensive care

2.1

38.1

463

2286

R74

ICPC

Upper respiratory infection acute

1.5

38.1

1645

11849

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

6.8

38.0

143

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

38.0

588

3188

A08

ICPC

Swelling

2.4

37.9

327

1375

130

Kela drug reimbursment

Malignant tumour

1.8

37.5

702

4063

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

37.4

518

2695

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

37.4

432

2086

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

37.3

4552

39251

SPAT1260

SPAT

Consultation of another employee

1.5

37.3

1268

8653

C08DA01

ATC

verapamil; systemic

2.4

37.2

331

1413

C08DB01

ATC

diltiazem; oral

2.2

37.1

414

1968

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

37.0

455

2255

UJF32

NOMESCO Finland

Coloscopy

1.4

37.0

1924

14368

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

8.0

37.0

107

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

36.8

882

5498

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

36.7

1191

8034

WX721

NOMESCO Finland

Oxygen concentrator therapy

20.9

36.5

R03DA05

ATC

aminophylline; systemic, rectal

5.9

36.4

104

178

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

36.3

404

1919

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

9.6

36.3

N05AD03

ATC

melperone; systemic

4.0

36.3

150

381

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.1

36.2

117

232

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

35.9

431

2114

N03AE01

ATC

clonazepam; systemic

2.0

35.9

458

2306

P76

ICPC

Depressive disorder

2.2

35.9

381

1773

P03

ICPC

Feeling depressed

2.0

35.8

485

2500

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

4.1

35.8

142

347

N05BB01

ATC

hydroxyzine; systemic

2.0

35.4

450

2261

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

6.3

35.3

151

F34.1

ICD-10 Finland

Dysthymia

2.6

35.2

261

1010

188

Kela drug reimbursment

Psychosis requiring demanding treatment

4.7

35.2

122

261

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

34.8

598

3358

F17.3

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, withdrawal state

24.6

34.8

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

34.6

1214

8333

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.6

34.5

260

1016

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

34.5

904

5773

SPAT1104

SPAT

Monitoring of emergency patient

1.9

34.4

505

2684

30041

ICD-8 Finland

Neuroses, Depressiva

4.0

34.4

141

356

RS221

NOMESCO Finland

3.7

34.4

156

430

J43.1

ICD-10 Finland

Panlobular emphysema

39.3

34.3

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

15.1

34.3

E87.6

ICD-10 Finland

Hypokalaemia

2.7

34.3

242

910

L03

ICPC

Low back symptom/complaint

1.5

34.2

1568

11395

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

3.1

34.1

191

618

R03CC02

ATC

salbutamol; systemic

2.6

34.1

261

1029

GDC00

NOMESCO Finland

Lobectomy of lung

6.0

34.1

162

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.8

34.0

147

389

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

33.9

391

1884

R03AC04

ATC

fenoterol; inhalant

8.5

33.9

SPAT1234

SPAT

Support of social functional capacity

2.2

33.6

350

1613

J01FA10

ATC

azithromycin; systemic

1.3

33.6

4001

34143

UJD02

NOMESCO Finland

Gastroscopy

2.1

33.4

385

1858

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

33.2

970

6363

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

8.5

33.2

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.1

33.0

382

1844

S76

ICPC

Skin infection other

2.1

33.0

384

1859

N06AB05

ATC

paroxetine; oral

2.0

32.8

445

2296

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.9

32.5

160

R05CB03

ATC

carbocisteine; oral

3.0

32.5

194

656

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

4.1

32.5

130

321

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.4

32.3

279

1174

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.6

32.3

245

959

W19

ICD-10 Finland

Unspecified fall

1.7

32.3

661

3929

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

32.3

321

1449

N05CD02

ATC

nitrazepam; oral

3.4

32.3

164

495

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

32.2

1418

10209

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.0

32.2

442

2291

J15.8

ICD-10 Finland

Other bacterial pneumonia

5.7

32.1

167

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

6.7

31.8

123

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

5.4

31.8

181

JN4BD

NOMESCO Finland

Extensive body CT

1.6

31.7

857

5510

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

20.5

31.7

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

31.6

433

2240

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.7

31.6

121

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

31.5

152

441

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

31.5

770

4820

C10AA01

ATC

simvastatin; oral

1.3

31.4

3415

28655

N05AF01

ATC

flupentixol; systemic

3.4

31.4

158

474

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

31.3

472

2533

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

31.3

589

3411

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.3

31.3

300

1331

R79

ICPC

Chronic bronchitis

18.6

31.3

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

31.2

459

2440

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.8

31.2

136

363

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.8

31.2

211

774

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

31.1

593

3446

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

5.2

31.1

190

F20.5

ICD-10 Finland

Residual schizophrenia

6.2

31.0

139

R05CB02

ATC

bromhexine; systemic

3.4

30.9

153

453

K07

ICPC

Swollen ankles/oedema

2.3

30.9

303

1360

J01MA02

ATC

ciprofloxacin; systemic

1.3

30.8

2949

24262

J02AC01

ATC

fluconazole; systemic

1.4

30.8

2385

18991

R07.3

ICD-10 Finland

Other chest pain

1.7

30.8

675

4091

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.5

30.8

112

253

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.5

30.8

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

30.7

641

3830

N06AA06

ATC

trimipramine; systemic

2.7

30.5

223

855

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.0

30.5

198

WX002

NOMESCO Finland

Sedation and analgesia

1.4

30.5

1425

10368

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

30.5

2845

23305

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

30.5

679

4136

I20.09

ICD-10 Finland

Unstable angina

1.9

30.5

475

2580

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

30.5

220

840

R03CC03

ATC

terbutaline; systemic

3.8

30.4

133

356

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

6.0

30.3

143

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

30.3

522

2935

N02AC04

ATC

dextropropoxyphene; oral

2.2

30.2

311

1424

SPAT1057

SPAT

Peak expiratory flow measurement

2.9

30.2

187

649

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

3.0

30.2

182

621

C08CA01

ATC

amlodipine; oral

1.3

30.1

2679

21780

Z08

ICPC

Social welfare problem

4.1

30.1

120

296

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

30.1

218

834

Z51.5

ICD-10 Finland

Palliative care

1.9

30.0

443

2356

A12BA01

ATC

potassium chloride; oral

2.2

29.9

316

1466

K59.0

ICD-10 Finland

Constipation

2.0

29.9

397

2032

P16

ICPC

Acute alcohol abuse

3.3

29.8

156

482

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.6

29.8

230

912

D07AA02

ATC

hydrocortisone; topical

1.6

29.7

866

5669

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.2

29.7

160

505

J01FA01

ATC

erythromycin; systemic

1.6

29.7

854

5573

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

29.6

351

1714

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

5.1

29.6

188

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.4

29.5

149

449

J86.9

ICD-10 Finland

Pyothorax without fistula

4.5

29.4

105

233

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.0

29.4

194

R13

ICD-10 Finland

Dysphagia

1.9

29.2

472

2595

Z94.2

ICD-10 Finland

Lung transplant status

12.7

29.2

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.7

29.2

201

746

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.2

29.2

114

276

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

29.2

1221

8684

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

10.8

29.1

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

29.0

371

1869

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

29.0

1155

8126

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.2

28.9

129

R01AD09

ATC

mometasone; nasal

1.3

28.8

3023

25133

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

4.5

28.8

103

229

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

28.7

1392

10190

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

28.7

280

1254

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.8

28.6

142

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.1

28.6

159

514

SPAT1229

SPAT

Assessment of need for aid

1.8

28.6

547

3182

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

5.1

28.5

179

J41.0

ICD-10 Finland

Simple chronic bronchitis

5.8

28.3

140

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

14.2

28.3

J01DA08

ATC

[U] cefaclor; oral

1.7

28.2

626

3809

30180

ICD-8 Finland

Personality disorders, Immatura

5.6

28.2

149

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

10.9

28.1

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

28.1

543

3167

E86

ICD-10 Finland

Volume depletion

2.8

28.1

189

692

PD3AT

NOMESCO Finland

Pelvic artery PTA

5.9

28.1

134

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

4.7

28.1

204

SPAT1310

SPAT

Counselling related to known health issue

1.3

28.0

2196

17468

A02BA03

ATC

famotidine; systemic

2.1

28.0

320

1540

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

27.9

1875

14544

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

27.9

174

608

GDG10

NOMESCO Finland

Bilateral transplantation of lung

14.3

27.8

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.2

27.8

152

486

E000003

ATC

2.1

27.8

325

1577

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.1

27.7

125

I50

ICD-10 Finland

Heart failure

2.6

27.7

214

851

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.1

27.5

152

489

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

11.6

27.5

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

27.5

258

1132

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

7.2

27.4

N02AA01

ATC

morphine; systemic, rectal

3.7

27.3

123

339

R06.5

ICD-10 Finland

Mouth breathing

1.6

27.2

670

4194

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

27.2

526

3069

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

5.9

27.2

132

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.4

27.1

241

1028

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

27.1

885

5951

SBA00

NOMESCO Finland

Microbiological examinations

2.7

26.9

185

685

R05

ICD-10 Finland

Cough

1.4

26.8

1270

9242

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

26.8

169

595

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

26.8

287

1341

A10BH01

ATC

sitagliptin; oral

1.6

26.7

734

4730

A01AB10

ATC

natamycin; local oral

2.5

26.7

210

840

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

5.7

26.7

135

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.9

26.6

431

2371

XF402

NOMESCO Finland

ECG with work load test

1.5

26.6

852

5703

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

26.5

246

1075

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.4

26.5

132

394

R52.0

ICD-10 Finland

Acute pain

2.5

26.5

215

876

M48.0

ICD-10 Finland

Spinal stenosis

1.5

26.4

866

5828

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

26.3

328

1638

SPAT1251

SPAT

Organisation of medication

2.3

26.2

260

1174

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.3

26.1

251

1114

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.0

26.0

156

531

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

5.2

26.0

156

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

4.7

25.9

195

G44.2

ICD-10 Finland

Tension-type headache

1.6

25.8

775

5107

N05AL01

ATC

sulpiride; systemic

3.1

25.7

141

453

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.8

25.6

110

291

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

25.6

728

4732

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

25.6

1613

12354

L30.3

ICD-10 Finland

Infective dermatitis

2.2

25.5

261

1195

4289X

ICD-9 Finland

Heart failure, unspecified

7.2

25.4

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

25.4

2668

22078

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.6

25.4

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

25.4

5029

45170

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

3.0

25.3

148

496

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

25.2

289

1393

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

5.8

25.2

125

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

25.1

223

954

SPF30

NOMESCO Finland

Soling for prothesis

2.9

25.1

159

562

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

5.5

25.0

138

SPAT1211

SPAT

Application of soft bandage

1.7

25.0

590

3650

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

4.2

25.0

230

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

4.7

25.0

185

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.5

24.8

119

346

RS220

NOMESCO Finland

3.5

24.7

117

336

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.2

24.7

223

-50

ICPC

Medication/prescr/renewal

2.0

24.7

310

1551

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

24.7

394

2157

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.1

24.7

291

1417

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.7

24.7

172

644

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

5.7

24.6

125

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

24.5

1538

11757

PEN23

NOMESCO Finland

Plastic repair of femoral artery

4.2

24.5

225

N06AG02

ATC

moclobemide; oral

2.0

24.5

332

1714

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

4.4

24.5

207

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

8.4

24.4

N06AB08

ATC

fluvoxamine; oral

2.3

24.3

221

958

OAB43

SPAT

0.6

24.3

326

5538

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

5.0

24.3

160

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

24.1

448

2580

R52.2

ICD-10 Finland

Other chronic pain

2.3

24.1

232

1031

N06AA10

ATC

nortriptyline; systemic

2.7

24.1

172

652

SPAT1097

SPAT

Recording of ECG

1.5

24.1

1038

7402

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

7.3

24.1

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.9

24.1

253

A10BB12

ATC

glimepiride; oral

1.7

24.1

547

3346

S18

ICPC

Laceration/cut

1.3

24.1

3023

25573

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.1

24.1

282

1372

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

24.0

458

2658

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.9

24.0

162

RK250

NOMESCO Finland

5.5

24.0

129

L57.0

ICD-10 Finland

Actinic keratosis

0.5

23.9

233

4312

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.2

23.9

221

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

23.8

254

1188

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.6

23.7

110

311

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

23.7

524

3181

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.8

23.5

418

2374

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

23.5

169

645

E66

ICD-10 Finland

Obesity

2.1

23.5

278

1359

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.8

23.4

157

575

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.5

23.4

110

315

R10.0

ICD-10 Finland

Acute abdomen

2.3

23.3

227

1015

SPAT1252

SPAT

Overall medication plan or its review

1.7

23.2

485

2898

A02BX02

ATC

sucralfate; oral

2.0

23.1

304

1553

T82

ICPC

Obesity

2.2

23.0

238

1094

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

23.0

3315

28485

D07AB08

ATC

desonide; topical

1.6

23.0

666

4347

Z71.8

ICD-10 Finland

Other specified counselling

1.4

22.9

1441

11007

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

22.9

482

2883

N30.0

ICD-10 Finland

Acute cystitis

1.5

22.9

722

4811

K92.0

ICD-10 Finland

Haematemesis

2.4

22.8

201

856

F20.10

ICD-10 Finland

Raise schizophrenia continuously

6.4

22.8

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

22.8

1587

12321

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

22.7

803

5487

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.7

22.7

267

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

22.7

1014

7281

B37.0

ICD-10 Finland

Candidal stomatitis

4.1

22.6

214

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.7

22.6

153

565

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

22.6

134

455

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.2

22.6

205

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.6

22.6

167

648

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

22.5

385

2159

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

22.5

278

1384

PE1AT

NOMESCO Finland

Femoral artery PTA

3.4

22.5

110

325

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

22.5

330

1753

M10.9

ICD-10 Finland

Gout, unspecified

1.7

22.3

507

3100

SPE01

NOMESCO Finland

Mucosa-supported partial denture

3.0

22.3

134

456

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

22.3

271

1338

B01AB05

ATC

enoxaparin; parenteral

1.3

22.3

2131

17338

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.9

22.2

137

477

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

10.0

22.2

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

22.1

418

2422

K70.1

ICD-10 Finland

Alcoholic hepatitis

4.5

22.1

177

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.3

22.1

191

X57

ICD-10 Finland

Unspecified privation

2.5

22.1

175

707

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

22.0

241

1138

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.4

22.0

187

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.2

22.0

118

374

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

6.5

21.9

S06.0

ICD-10 Finland

Concussion

1.6

21.9

639

4176

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.7

21.9

270

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.9

21.9

317

1675

C07AA05

ATC

propranolol; systemic

1.4

21.8

1195

8908

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.4

21.7

188

796

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

21.6

897

6340

T74.1

ICD-10 Finland

Physical abuse

3.1

21.5

117

375

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

4.5

21.5

169

P28

ICPC

Limited function/disability (P)

4.6

21.4

165

A10BK03

ATC

empagliflozin; oral

1.6

21.4

543

3427

R03

ICPC

Wheezing

3.6

21.3

271

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

5.2

21.3

127

DQA10

NOMESCO Finland

Biopsy of larynx

5.0

21.3

140

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.2

21.2

213

970

R01

ICPC

Pain respiratory system

3.1

21.2

118

385

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

21.1

327

1772

V03AB30

ATC

3.7

21.1

248

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.3

21.1

181

SPAT1284

SPAT

Extensive health certificate

2.3

21.1

199

879

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

21.1

374

2122

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

6.1

20.9

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

20.9

126

431

GBB00

NOMESCO Finland

Tracheostomy

3.2

20.9

111

350

K92.1

ICD-10 Finland

Melaena

1.8

20.9

367

2078

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

20.9

245

1195

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.1

20.9

202

R84

ICPC

Malignant neoplasm bronchus/lung

6.9

20.9

SPA47

NOMESCO Finland

Precision impression for denture

2.6

20.8

150

575

WZA90

NOMESCO Finland

Other doctors statement

1.3

20.8

1493

11625

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.8

20.8

377

2153

J94.8

ICD-10 Finland

Other specified pleural conditions

2.8

20.8

136

491

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

2.3

20.7

201

900

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

7.9

20.6

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

20.6

388

2243

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

20.6

357

2012

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

6.9

20.6

A10AE05

ATC

insulin detemir; parenteral

1.8

20.6

384

2216

R52.9

ICD-10 Finland

Pain, unspecified

1.6

20.5

536

3405

F20

ICD-10 Finland

Schizophrenia

4.6

20.5

159

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

10.3

20.5

R05DB05

ATC

pentoxyverine; oral, rectal

2.0

20.5

256

1281

D11

ICPC

Diarrhoea

1.6

20.5

594

3874

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

20.4

535

3402

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.5

20.4

281

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.1

20.4

232

1115

D01

ICPC

Abdominal pain/cramps general

1.6

20.4

584

3801

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

20.4

1936

15709

N06AA04

ATC

clomipramine; systemic

2.7

20.3

143

541

F17.1

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, harmful use

20.1

20.3

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

3.2

20.3

110

352

R01AD08

ATC

fluticasone; nasal

1.3

20.3

1817

14616

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

12.5

20.3

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.0

20.2

251

1250

SPAT1312

SPAT

General health counselling

1.3

20.2

2029

16578

A10BJ02

ATC

liraglutide; parenteral

2.3

20.2

193

860

2959C

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]

5.8

20.1

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

20.1

172

726

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

20.0

144

553

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

19.9

275

1432

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

19.9

307

1665

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

19.8

190

846

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

19.8

318

1745

F17.22

ICD-10 Finland

Addiction-related addiction currently uses controlled substitution treatment

10.0

19.8

N06AX05

ATC

trazodone; oral

2.3

19.8

178

769

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

19.7

169

711

L84

ICD-10 Finland

Corns and callosities

2.1

19.7

229

1110

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

19.7

2956

25380

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

3.3

19.7

100

306

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

19.6

1136

8537

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

16.4

19.6

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.8

19.6

124

440

RS230

NOMESCO Finland

5.2

19.6

119

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

7.7

19.5

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

19.5

543

3507

TK800

NOMESCO Finland

Hemodialysis

2.3

19.4

187

834

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.1

19.4

223

1079

F32

ICD-10 Finland

Depressive episode

1.9

19.4

285

1516

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

19.4

1801

14550

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

19.3

830

5903

I73.9

ICD-10 Finland

Peripheral vascular disease, unspecified

3.8

19.3

212

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

19.3

178

778

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

19.3

354

2032

49099

ICD-8 Finland

Bronchitis, unspecified

3.1

19.2

106

344

A99

ICPC

Disease/condition unspecnature/site

1.6

19.2

498

3159

R39

ICPC

Respiratory, Physical function test

4.9

19.2

126

K85

ICD-10 Finland

Acute pancreatitis

2.5

19.1

147

586

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.5

19.1

643

4344

2959E

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]

5.9

19.1

PEH56

NOMESCO Finland

Bypass from femoral to popliteal artery above knee

4.0

19.1

195

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

19.1

130

482

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.0

19.1

255

1310

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

4.7

19.0

140

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

19.0

433

2650

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.5

19.0

152

618

SPAT1265

SPAT

Breathalyser

3.4

19.0

282

L14

ICPC

Leg/thigh symptom/complaint

1.7

19.0

449

2777

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.8

18.9

316

1757

R33

ICD-10 Finland

Retention of urine

1.5

18.9

595

3956

SPAT1281

SPAT

Other administrative function

1.6

18.8

505

3229

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

5.8

18.8

J01EA01

ATC

trimethoprim; systemic

1.3

18.8

1409

11034

L16

ICPC

Ankle symptom/complaint

1.5

18.7

584

3877

WX290

NOMESCO Finland

Other blockade of nerve

1.2

18.6

2825

24240

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

18.6

525

3400

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.5

18.6

ZXA00

NOMESCO Finland

Right side

1.3

18.6

1872

15274

OAA67

SPAT

0.5

18.6

120

2519

2959A

ICD-9 Finland

Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]

6.3

18.6

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.9

18.6

111

381

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

20.8

18.6

PH2CD

NOMESCO Finland

Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity

4.5

18.6

144

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

18.5

1496

11836

F41.00

ICD-10 Finland

Moderate panic disorder

3.2

18.5

299

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

4.0

18.4

182

I20.00

ICD-10 Finland

Unstable angina

2.0

18.4

233

1173

J98.2

ICD-10 Finland

Interstitial emphysema

15.0

18.4

UKC02

NOMESCO Finland

Cystoscopy

1.4

18.4

1196

9155

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

18.4

634

4304

M70.2

ICD-10 Finland

Olecranon bursitis

1.9

18.3

270

1438

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

7.4

18.3

R4120

NOMESCO Finland

Occupational therapy

1.7

18.3

414

2533

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.9

18.3

289

1579

P74

ICPC

Anxiety disorder/anxiety state

2.3

18.2

169

743

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

11.8

18.2

ECB00

NOMESCO Finland

Suture of gingiva

1.9

18.2

255

1336

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

18.2

113

398

-1

NOMESCO Finland

1.3

18.1

2060

17062

SPAT1241

SPAT

Extensive assessment of psychosocial situation

3.8

18.1

205

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.5

18.0

142

572

R24

ICPC

Haemoptysis

4.3

18.0

153

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.1

18.0

201

962

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

18.0

506

3276

N05CF02

ATC

zolpidem; oral

1.4

18.0

1107

8396

SPAT1216

SPAT

Assessment of functional ability

1.4

18.0

954

7055

WX704

NOMESCO Finland

Intubation

1.6

18.0

466

2955

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.0

17.9

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.9

17.9

107

368

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

5.3

17.9

102

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

5.4

17.9

SPAT1325

SPAT

Vaccination

1.3

17.9

2241

18786

N01

ICPC

Headache

1.6

17.9

449

2825

N05AA03

ATC

promazine; systemic

8.7

17.8

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

17.8

256

1354

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.3

17.8

162

705

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.0

17.8

243

1261

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.8

17.8

113

402

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

17.7

1151

8805

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

17.7

210

1030

I74.3

ICD-10 Finland

Embolism and thrombosis of arteries of lower extremities

3.3

17.7

271

S29

ICPC

Skin symptom/complaint other

1.4

17.7

1044

7862

J01CF05

ATC

flucloxacillin; systemic

1.9

17.7

259

1380

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.2

17.6

D07AC13

ATC

mometasone; topical

1.3

17.6

1924

15847

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.0

17.6

229

1166

M05BA07

ATC

risedronic acid; oral

2.3

17.6

167

743

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

6.5

17.6

PD3BT

NOMESCO Finland

Pelvic artery extensive PTA

7.5

17.6

3041A

ICD-9 Finland

Drug dependence, Barbiturate and similarly acting sedative or hypnotic dependence

12.4

17.6

GX2C5

NOMESCO Finland

Short-lasting oximetry

12.4

17.6

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.9

17.5

247

1294

160

Kela drug reimbursment

exenatide

2.3

17.5

169

758

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

4.1

17.4

163

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.0

17.4

223

1127

M54.3

ICD-10 Finland

Sciatica

1.7

17.4

377

2277

R55

ICD-10 Finland

Syncope and collapse

1.5

17.4

688

4811

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

1.7

17.4

351

2076

K12.2

ICD-10 Finland

Cellulitis and abscess of mouth

3.3

17.4

259

J01DC02

ATC

cefuroxime; systemic

1.7

17.4

363

2171

V03AA02

ATC

8.6

17.3

XG420

NOMESCO Finland

Time-volume spirometry

16.9

17.3

ZXA05

NOMESCO Finland

Left side

1.3

17.3

1735

14127

G02BA03

ATC

plastic IUD with progestogen

0.5

17.3

147

2834

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

5.7

17.3

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

17.2

412

2558

ZX108

NOMESCO Finland

Inhalation

3.7

17.2

209

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

17.2

144

602

P06

ICPC

Sleep disturbance

1.5

17.2

569

3829

R05DB20

ATC

other cough suppressants - combinations

1.7

17.2

342

2016

RK320

NOMESCO Finland

3.4

17.2

251

A10BJ06

ATC

semaglutide; parenteral

1.9

17.1

240

1256

UDQ22

NOMESCO Finland

Microlaryngoscopy

3.6

17.1

215

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

17.1

184

867

X58

ICD-10 Finland

Exposure to other specified factors

1.4

17.1

864

6332

30188

ICD-8 Finland

Personality disorders, Alia definita

4.7

17.1

125

29999

ICD-8 Finland

Unspecified psychosis

4.7

17.1

125

N05AX13

ATC

paliperidone; systemic

6.3

17.1

E000006

ATC

1.6

17.1

418

2611

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.1

17.0

200

977

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.7

17.0

196

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.1

17.0

188

896

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

17.0

363

2185

R07.1

ICD-10 Finland

Chest pain on breathing

2.8

17.0

110

398

2953E

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN AKUUTTI]

7.1

17.0

N17.8

ICD-10 Finland

Other acute renal failure

3.1

16.9

303

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

10.7

16.9

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

16.9

178

832

L01

ICPC

Neck symptom/complaint

1.4

16.9

768

5520

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

2.7

16.8

114

424

B37.08

ICD-10 Finland

Other candidal stomatitis

4.1

16.8

159

F1246

NOMESCO Finland

9.5

16.8

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.9

16.8

266

1457

SPAT1227

SPAT

Substance abuse rehabilitation

4.0

16.8

164

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.3

16.8

148

636

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

16.8

227

1175

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

6.3

16.8

K29.2

ICD-10 Finland

Alcoholic gastritis

5.8

16.7

SPD01

NOMESCO Finland

Mucosa-supported complete denture

3.6

16.7

210

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.9

16.6

102

356

R42

ICD-10 Finland

Dizziness and giddiness

1.3

16.6

1328

10479

ICD-9 Finland

4.4

16.6

138

SPAT1360

SPAT

Extensive global examination

1.6

16.6

476

3099

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

16.5

548

3687

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

16.5

596

4083

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

5.8

16.5

J93.8

ICD-10 Finland

Other pneumothorax

5.4

16.5

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

16.5

1414

11261

29599

ICD-8 Finland

Schizophrenia, Unspecified type

4.0

16.5

167

Z00.0

ICD-10 Finland

General medical examination

1.3

16.5

1182

9176

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

16.5

303

-69

ICPC

Other reason for encounter NEC

1.9

16.4

253

1373

L86

ICPC

Back syndrome with radiating pain

1.7

16.4

337

2004

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.4

16.4

142

604

R4190

NOMESCO Finland

Nutritional therapy

2.0

16.4

213

1083

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.9

16.4

224

1164

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

16.4

562

3810

29580

ICD-8 Finland

Schizophrenia, Other

4.3

16.4

140

L05

ICPC

Flank/axilla symptom/complaint

1.7

16.3

343

2055

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.4

16.3

138

580

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

4.2

16.3

150

D05AX52

ATC

calcipotriol, combinations; topical

1.7

16.3

374

2297

PD4CM

NOMESCO Finland

Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet

6.6

16.2

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.6

16.2

123

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

16.2

572

3902

6350C

ICD-9 Finland

Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]

1.9

16.2

235

1249

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.9

16.2

222

1156

K29.1

ICD-10 Finland

Other acute gastritis

2.8

16.1

106

388

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

10.4

16.1

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.4

16.1

133

551

F20.02

ICD-10 Finland

Paranoid schizophrenia stable periodically

6.0

16.1

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

5.8

16.1

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

30.1

16.1

F60.8

ICD-10 Finland

Other specific personality disorders

4.6

16.1

120

R05DA01

ATC

ethylmorphine; oral

1.5

16.1

526

3531

ZXA10

NOMESCO Finland

Bilateral

1.3

16.0

1167

9075

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

16.0

648

4550

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

0.5

16.0

141

2686

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.9

16.0

332

M54

ICD-10 Finland

Dorsalgia

1.5

16.0

632

4417

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.6

16.0

116

450

XF404

NOMESCO Finland

Ambulatory ECG

1.5

16.0

619

4310

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.8

15.9

284

1616

ZZA00

NOMESCO Finland

Split skin graft

2.0

15.9

216

1120

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

15.9

306

1787

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

15.9

372

2296

D75.1

ICD-10 Finland

Secondary polycythaemia

3.8

15.9

173

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

4.6

15.9

117

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

15.8

121

481

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

15.8

381

2373

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

15.7

1565

18879

JN4AD

NOMESCO Finland

Body CT examination

1.5

15.7

544

3697

A29

ICPC

General symptom/complaint other

1.4

15.7

674

4792

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

5.7

15.6

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

12.9

15.6

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.4

15.6

131

550

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

15.6

140

608

RS222

NOMESCO Finland

3.0

15.6

309

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.9

15.6

321

S01.0

ICD-10 Finland

Open wound of scalp

1.5

15.6

507

3400

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

2.8

15.5

101

367

TGD00

NOMESCO Finland

Needle biopsy of lung

4.7

15.5

111

D07XC01

ATC

betamethasone, combinations; topical

1.4

15.5

814

6002

30088

ICD-8 Finland

Neuroses, Other

4.1

15.5

143

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.1

15.5

266

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.7

15.5

104

383

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.8

15.5

246

1349

R06.4

ICD-10 Finland

Hyperventilation

2.7

15.4

102

375

OAB48

SPAT

0.5

15.4

140

2644

M01AB51

ATC

indometacin, combinations; oral, rectal

2.1

15.4

181

887

F32.8

ICD-10 Finland

Other depressive episodes

3.0

15.4

300

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

5.1

15.4

G03AC03

ATC

levonorgestrel; systemic

0.6

15.4

271

4321

F61

ICD-10 Finland

Mixed and other personality disorders

4.6

15.3

117

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.8

15.3

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.7

15.3

104

388

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

3.9

15.3

164

E000002

ATC

1.5

15.3

629

4431

L72.1

ICD-10 Finland

Trichilemmal cyst

1.6

15.3

393

2489

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.6

15.2

410

2624

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.6

15.2

397

2527

Z00.8

ICD-10 Finland

Other general examinations

1.6

15.1

421

2721

N06AX26

ATC

vortioxetine; oral

1.8

15.1

275

1580

97010

ICD-8 Finland

Adverse effect of psychotherapeutics, Tranquillisers

5.1

15.1

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

15.1

196

998

SPF11

NOMESCO Finland

Fitting of dental prosthesis

3.5

15.1

202

49209

ICD-8 Finland

Emphysema, Unspecified

45.0

15.0

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.3

15.0

141

625

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

15.0

162

766

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.4

15.0

129

547

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.9

15.0

204

1059

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.6

14.9

356

2211

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

14.9

230

1251

RS224

NOMESCO Finland

5.4

14.9

H02AB09

ATC

hydrocortisone; systemic

2.2

14.9

148

675

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

14.8

599

4202

F60.2

ICD-10 Finland

Dissocial personality disorder

6.5

14.8

K02.1

ICD-10 Finland

Caries of dentine

1.2

14.8

3796

34129

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

14.8

181

900

F31

ICD-10 Finland

Bipolar affective disorder

2.9

14.8

298

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

3.9

14.7

155

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.4

14.7

125

528

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

5.8

14.7

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.1

14.7

260

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

14.7

1810

15077

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

14.7

351

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.0

14.6

182

912

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

14.6

786

5818

IGV01

NOMESCO Finland

Psychiatric network contact

5.1

14.6

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

6.5

14.5

M02AA07

ATC

piroxicam; topical

1.2

14.5

2481

21422

J38.3

ICD-10 Finland

Other diseases of vocal cords

2.8

14.5

318

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

0.5

14.5

142

2624

R04.0

ICD-10 Finland

Epistaxis

1.5

14.5

465

3108

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

14.5

565

7743

C09AA02

ATC

enalapril; systemic

1.3

14.4

1387

11199

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

14.4

291

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

6.7

14.4

J80

ICD-10 Finland

Adult respiratory distress syndrome

5.5

14.4

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.0

14.4

185

940

M79.7

ICD-10 Finland

Fibromyalgia

2.1

14.4

171

840

120

Kela drug reimbursment

Hypogammaglobulinaemia

8.8

14.4

Angiography of the heart and coronary arteries

1.5

14.4

444

2941

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

14.4

116

477

L20.0

ICD-10 Finland

Besnier prurigo

1.7

14.4

286

1687

M25.5

ICD-10 Finland

Pain in joint

1.3

14.4

1755

14602

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.7

14.3

327

2008

D09AB01

ATC

zinc bandage without supplements; topical

2.3

14.3

134

595

D02AE01

ATC

carbamide; topical

1.6

14.3

414

2698

R05CA10

ATC

expectorants - combinations

2.2

14.3

149

695

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

14.3

576

4044

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.2

14.2

139

631

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.0

14.2

141

F2680

NOMESCO Finland

8.6

14.2

F2682

NOMESCO Finland

8.6

14.2

Y3409

ICD-8 Finland

Follow-up examination of illness, accident or surgery, Treated inactive pulmonary tuberculosis

9.1

14.1

C34.01

ICD-10 Finland

Malignant tumor of the main bronchial epidermoid carcinoma

9.1

14.1

PEF24

NOMESCO Finland

Thrombendarterectomy of deep femoral artery

4.5

14.1

109

L01CA04

ATC

vinorelbine; systemic

3.4

14.1

197

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

5.5

14.1

S20.2

ICD-10 Finland

Contusion of thorax

1.7

14.1

316

1927

ZPB22

NOMESCO Finland

Autograft of vein

4.2

14.1

123

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

4.9

14.1

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.1

14.1

152

718

7803A

ICD-9 Finland

General symptoms, Convulsions

3.3

14.1

219

N06DA02

ATC

donepezil; oral

0.4

14.1

1739

K56.0

ICD-10 Finland

Paralytic ileus

3.0

14.1

263

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

3.3

14.0

209

A11

ICPC

Chest pain NOS

1.5

14.0

450

3010

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

5.8

14.0

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

5.4

14.0

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

8.4

13.9

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

9.4

13.9

S06

ICPC

Rash localized

1.6

13.9

319

1962

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

15.8

13.9

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

13.9

246

1402

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.2

13.9

138

628

C34.91

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma

7.5

13.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

13.9

197

1039

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

13.8

3805

34356

280

Kela drug reimbursment

Clopidogrel

2.4

13.8

118

499

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.7

13.8

351

J43.0

ICD-10 Finland

MacLeod syndrome

53.4

13.8

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.5

13.8

110

452

53502

ICD-8 Finland

Gastritis and duodenitis, Gastritis acuta NUD

3.7

13.8

160

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

3.0

13.7

256

L02

ICPC

Back symptom/complaint

1.5

13.7

472

3203

F22.0

ICD-10 Finland

Delusional disorder

2.5

13.7

103

409

M03BX02

ATC

tizanidine; oral

1.2

13.7

4370

39968

A07AA09

ATC

vancomycin; oral

2.7

13.7

354

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

4.2

13.7

122

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

13.6

13.7

P80

ICPC

Personality disorder

5.6

13.7

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.2

13.6

132

596

N61

ICD-10 Finland

Inflammatory disorders of breast

2.7

13.6

348

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

13.6

654

4747

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

13.6

228

1274

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

13.6

340

2139

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

6.9

13.6

61207

ICD-8 Finland

Acute salpingitis and oophoritis, suspecta

3.4

13.5

188

K04.0

ICD-10 Finland

Pulpitis

1.5

13.5

523

3639

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

13.5

410

2707

RF220

NOMESCO Finland

2.4

13.5

108

444

51899

ICD-8 Finland

Bronchiectasis

6.6

13.5

SPAT1283

SPAT

Restricted health certificate

1.4

13.5

778

5827

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.1

13.5

150

719

U13

ICPC

Bladder symptom/complaint other

2.0

13.4

164

817

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

13.4

572

4060

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.3

13.4

121

528

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

2.5

13.3

100

397

P73

ICPC

Affective psychosis

4.8

13.3

E66.0

ICD-10 Finland

Obesity due to excess calories

2.8

13.3

302

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

3.0

13.3

261

RK110

NOMESCO Finland

3.3

13.3

207

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.4

13.2

181

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

8.1

13.2

A03FA02

ATC

cisapride; oral, rectal

1.5

13.2

473

3236

PEH57

NOMESCO Finland

Bypass from femoral artery to popliteal artery below knee

3.5

13.2

176

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

5.7

13.2

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

3.9

13.2

136

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.7

13.2

344

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

13.2

667

4881

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

13.2

363

2341

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

2.5

13.1

395

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

13.1

431

6080

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

13.1

274

1642

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

3.1

13.1

237

TQW80

NOMESCO Finland

Local dermatologic skincare

2.0

13.1

174

896

H25.8

ICD-10 Finland

Other senile cataract

1.4

13.1

603

4345

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

2.9

13.1

277

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.1

13.0

148

718

BC1AD

NOMESCO Finland

CT of adrenal glands

3.1

13.0

221

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.1

13.0

152

745

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.0

13.0

253

D02AX

ATC

Other emollients and protectives

1.9

13.0

176

914

K11.2

ICD-10 Finland

Sialoadenitis

1.9

13.0

184

971

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

3.3

13.0

200

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

8.3

13.0

T07

ICPC

Weight gain

3.5

12.9

174

J01GB01

ATC

tobramycin; inhalant, parenteral

28.4

12.9

Z01

ICPC

Poverty/financial problem

5.7

12.9

PEF25

NOMESCO Finland

Thrombendarterectomy of superficial femoral artery

4.2

12.9

115

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.6

12.9

159

K70.0

ICD-10 Finland

Alcoholic fatty liver

3.2

12.9

212

S99.9

ICD-10 Finland

Unspecified injury of ankle and foot

2.3

12.9

119

527

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

12.9

367

2385

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.7

12.9

314

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.0

12.9

166

846

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

12.8

408

2721

TGA30

NOMESCO Finland

Thoracocentesis

3.3

12.8

186

207

Kela drug reimbursment

Chronic arrhythmias

1.3

12.8

931

7230

R1250

NOMESCO Finland

Evaluation of functional capability

2.1

12.8

148

723

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.0

12.8

159

800

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.3

12.8

115

503

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

12.8

259

1541

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

6.5

12.7

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

6.5

12.7

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.9

12.7

172

894

PDQ20

NOMESCO Finland

Insertion of endovascular graft into common iliac artery

3.9

12.7

131

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.6

12.7

207

3358

R09.1

ICD-10 Finland

Pleurisy

2.4

12.7

108

457

XKC03

NOMESCO Finland

Water cystometry

1.9

12.7

186

995

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

12.7

761

5733

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.0

12.7

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.2

12.7

123

557

309

Kela drug reimbursment

Nalmefene and naltrexone

4.0

12.7

122

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.1

12.7

137

649

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

6.0

12.7

K05.3

ICD-10 Finland

Chronic periodontitis

1.6

12.6

351

2270

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

12.6

404

2697

D09

ICPC

Nausea

1.9

12.6

177

932

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

7.0

12.5

Y07

ICD-10 Finland

Other maltreatment

3.7

12.5

143

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

6.1

12.5

XA420

NOMESCO Finland

Extensive sleep examination

2.5

12.5

391

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

12.5

406

5740

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.4

12.5

174

61208

ICD-8 Finland

Acute salpingitis and oophoritis, Alia definita

4.7

12.5

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

6.6

12.4

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

6.6

12.4

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.5

12.4

373

2454

U04

ICPC

Incontinence urine

1.7

12.4

236

1375

2953C

ICD-9 Finland

Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]

6.3

12.4

RD210

NOMESCO Finland

2.3

12.4

112

491

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

2.0

12.4

147

727

K03.64

ICD-10 Finland

Dental calculus supragingival

0.8

12.4

1106

13555

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

1.7

12.4

280

1715

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

6.0

12.4

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

4.7

12.4

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

4.7

12.4

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.2

12.3

125

577

PWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system

4.2

12.3

111

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

12.3

204

1139

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

12.3

242

1425

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

8.0

12.3

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.1

12.3

220

E970A

ICD-9 Finland

Injury due to legal intervention by firearms

6.5

12.3

L08

ICPC

Shoulder symptom/complaint

1.3

12.3

1183

9547

P18

ICPC

Medication abuse

4.4

12.2

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

9.6

12.2

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

4.7

12.2

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.6

12.2

322

2055

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

12.2

173

914

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.9

12.1

183

989

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

4.8

12.1

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

12.1

1245

C07AB02

ATC

metoprolol; systemic

1.3

12.1

1368

11255

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

7.7

12.1

K56.7

ICD-10 Finland

Ileus, unspecified

2.2

12.1

115

515

B01AC07

ATC

dipyridamole; systemic

1.6

12.0

293

1831

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.4

12.0

164

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

4.3

12.0

100

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.0

12.0

233

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

12.0

751

5697

K61.0

ICD-10 Finland

Anal abscess

2.3

12.0

107

467

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

3.1

12.0

213

8511

FHL

Cervical dilation and drainage with suction

1.9

12.0

170

902

WZA10

NOMESCO Finland

Long statement of health and health related matters

2.5

11.9

384

2954A

ICD-9 Finland

Schizophrenic psychoses, Acute schizophrenic episode

4.6

11.9

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

1.9

11.9

159

823

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

2.6

11.9

341

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

2.3

11.9

109

481

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

11.9

292

1830

F20.01

ICD-10 Finland

Paranoid schizophrenia periodically with gradual deterioration

5.9

11.9

48609

ICD-8 Finland

Pneumonia, unspecified

2.2

11.9

114

513

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.6

11.9

316

2023

WX890

NOMESCO Finland

Intesive care monitoring

3.1

11.9

203

R99

ICPC

Respiratory disease other

2.2

11.9

115

522

A05

ICPC

Feeling ill

1.7

11.9

252

1521

C02DE01

ATC

3.0

11.8

215

K28

ICPC

Limited function/disability (K)

2.1

11.8

138

677

N05AE04

ATC

ziprasidone; systemic

4.3

11.8

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

4.6

11.8

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

11.8

117

537

R03BC01

ATC

cromoglicic acid; inhalant

2.5

11.8

344

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.8

11.8

190

1052

R50

ICPC

Respiratory, Medication/prescr/renewal

6.1

11.8

PEN24

NOMESCO Finland

Plastic repair of deep femoral artery

4.7

11.8

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

11.7

607

4460

Z50.1

ICD-10 Finland

Other physical therapy

1.6

11.7

330

2143

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.6

11.7

267

1639

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

11.7

242

1448

M79.1

ICD-10 Finland

Myalgia

1.4

11.7

695

5227

S16

ICPC

Bruise/contusion

1.9

11.7

169

901

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

11.6

132

639

M81.4

ICD-10 Finland

Drug-induced osteoporosis

4.6

11.6

OAB95

SPAT

0.5

11.6

1455

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

3.2

11.6

190

A10BX07

ATC

[U] liraglutide; parenteral

2.3

11.6

105

462

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.5

11.6

153

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.0

11.6

146

741

J05AH02

ATC

oseltamivir; oral

3.5

11.6

148

F41.01

ICD-10 Finland

Severe panic disorder

4.5

11.6

S21

ICPC

Skin texture symptom/complaint

1.3

11.6

734

5580

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

11.5

116

2125

K30

ICD-10 Finland

Functional dyspepsia

1.4

11.5

585

4288

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

11.5

350

2312

A06AH03

ATC

naloxegol; oral

2.7

11.5

295

RJ411

NOMESCO Finland

3.6

11.5

139

UGC02

NOMESCO Finland

Rigid bronchoscopy

6.1

11.5

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.1

11.5

122

578

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

11.5

136

674

8041/3-C34.1

ICD-O-3

Small cell carcinoma, NOS, of upper lobe, lung

9.2

11.5

F20.8

ICD-10 Finland

Other schizophrenia

4.6

11.5

4169X

ICD-9 Finland

Chronic pulmonary heart disease, unspecified

120.1

11.4

R32

ICD-10 Finland

Unspecified urinary incontinence

2.0

11.4

144

729

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

11.4

179

982

J93.9

ICD-10 Finland

Pneumothorax, unspecified

4.0

11.4

110

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

4.8

11.4

F40.1

ICD-10 Finland

Social phobias

2.3

11.4

421

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

11.4

225

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

3.2

11.4

182

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.7

11.4

286

4236

SPAT1235

SPAT

Mental health, emotional support

3.6

11.4

140

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

3.2

11.3

188

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

2.4

11.3

378

L85.3

ICD-10 Finland

Xerosis cutis

2.9

11.3

233

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

6.0

11.3

L12

ICPC

Hand/finger symptom/complaint

1.3

11.3

793

6125

ACC53

NOMESCO Finland

Release of ulnar nerve

2.3

11.3

429

WF004

NOMESCO Finland

Palliative radiotherapy

2.0

11.3

132

651

-34

ICPC

Blood test

1.9

11.3

170

922

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

11.2

312

2020

N06AX17

ATC

milnacipran; oral

2.6

11.2

311

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.7

11.2

207

1196

NH1AD

NOMESCO Finland

Ankle and foot CT

2.1

11.2

125

604

S20

ICPC

Corn/callosity

2.1

11.2

127

617

SPAT1151

SPAT

Treatment of major wounds

2.4

11.2

383

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.5

11.2

142

K05.38

ICD-10 Finland

Other chronic periodontitis

1.8

11.2

179

990

G72.8

ICD-10 Finland

Other specified myopathies

2.3

11.2

104

464

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.1

11.1

103

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

11.1

483

3440

H26.02

ICD-10 Finland

Presenil cataract

1.8

11.1

182

1013

D02

ICPC

Abdominal pain epigastric

1.6

11.1

298

1913

M01AB55

ATC

diclofenac, combinations; oral

1.5

11.1

409

2820

J21.99

ICD-10 Finland

Acute bronchiolitis, unspecified

6.8

11.1

N17

ICPC

Vertigo/dizziness

1.4

11.1

583

4298

N03AF02

ATC

oxcarbazepine; oral

1.8

11.1

184

1030

S01

ICPC

Pain/tenderness of skin

1.7

11.1

234

1410

H01

ICPC

Ear pain/earache

1.4

11.1

522

3775

JAH00

NOMESCO Finland

Laparotomy

1.8

11.1

174

955

T08

ICPC

Weight loss

2.6

11.0

318

SPAT1244

SPAT

Occupational therapy

2.8

11.0

254

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.3

11.0

K20

ICD-10 Finland

Oesophagitis

2.2

11.0

109

501

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

2.7

11.0

261

4760A

ICD-9 Finland

Chronic laryngitis and laryngotracheitis, Chronic laryngitis

5.8

11.0

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.2

10.9

111

516

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.1

10.9

115

541

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

10.9

244

1491

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

6.6

10.9

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

4.3

10.9

N05BA05

ATC

potassium clorazepate; oral

2.7

10.9

273

J01MA01

ATC

ofloxacin; systemic

1.4

10.9

568

4180

R35

ICD-10 Finland

Polyuria

1.5

10.9

408

2825

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.7

10.9

257

97940

ICD-8 Finland

Alcohol in combination with specified medicinal agents, With psychopharmacological agents

6.2

10.9

RF120

NOMESCO Finland

2.5

10.9

330

K29

ICPC

Cardiovascular sympt/complt other

1.6

10.9

252

1559

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

10.9

546

3995

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

5.1

10.9

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

1.5

10.9

377

2569

U05

ICPC

Urination problems other

1.6

10.8

273

1725

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.1

10.8

189

K22.7

ICD-10 Finland

Barrett oesophagus

2.3

10.8

406

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.4

10.8

349

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.6

10.8

291

XG430

NOMESCO Finland

Spiroegometry

15.5

10.8

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.5

10.8

1669

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

2.5

10.8

335

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.4

10.8

432

3029

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

8.2

10.8

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

10.7

512

3713

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

2.9

10.7

224

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

8.8

10.7

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

10.7

277

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

9.6

10.7

B35.3

ICD-10 Finland

Tinea pedis

1.7

10.7

234

1425

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

10.7

623

4671

Z28

ICPC

Limited function/disability (Z)

4.2

10.7

AP1

Catheterization of the left side of the heart

2.1

10.7

113

532

L29

ICPC

Musculoskeletal sympt/complt other

1.5

10.7

415

2893

C34.0

ICD-10 Finland

Malignant neoplasm: Main bronchus

5.4

10.7

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.0

10.7

130

652

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

5.6

10.7

N05AB02

ATC

fluphenazine; systemic

3.4

10.7

148

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

1.7

10.6

221

1324

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

10.6

296

1918

SPAT1274

SPAT

Brief intervention in person with addiction symptoms

4.0

10.6

103

H26.3

ICD-10 Finland

Drug-induced cataract

3.3

10.6

159

R06AX27

ATC

desloratadine; oral

1.2

10.6

1470

12355

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

7.5

10.6

D12

ICPC

Constipation

1.8

10.6

189

1082

30799

ICD-8 Finland

Transient situational disturbances

4.5

10.6

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.4

10.6

424

2973

C10AA05

ATC

atorvastatin; oral

1.2

10.6

2799

25002

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

1.9

10.6

154

824

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.6

10.6

262

1650

H04.10

ICD-10 Finland

Dry eye syndrome

1.4

10.5

536

3931

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.9

10.5

156

841

29550

ICD-8 Finland

Latent schizophrenia

7.0

10.5

A10BH05

ATC

linagliptin; oral

1.6

10.5

290

1875

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

3.6

10.5

129

JN4CD

NOMESCO Finland

Very extensive body CT

1.6

10.5

263

1661

SPAT1353

SPAT

Intensive monitoring

3.3

10.5

150

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

10.5

431

3040

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

10.5

445

L04AA06

ATC

mycophenolic acid; systemic

2.1

10.5

121

593

PG2YT

NOMESCO Finland

Implantation of arterial endoprothesis not elsewhere classified

6.5

10.5

H60.8

ICD-10 Finland

Other otitis externa

1.9

10.4

153

821

L95

ICPC

Osteoporosis

1.9

10.4

145

764

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

10.4

329

2196

R85

ICPC

Malignant neopl respiratory other

7.3

10.4

F20.38

ICD-10 Finland

Undifferentiated schizophrenia other definite

7.3

10.4

D07AD01

ATC

clobetasol; topical

1.3

10.4

944

7549

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.2

10.4

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

5.6

10.4

F21

ICD-10 Finland

Schizotypal disorder

3.5

10.3

136

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

10.3

599

4488

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

4.8

10.3

GAA31

NOMESCO Finland

Thoracoscopy

4.8

10.3

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

3.8

10.3

111

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.0

10.3

123

613

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

10.3

286

1853

PDQ22

NOMESCO Finland

Insertion of endovascular graft into a. iliaca externa

4.9

10.3

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

10.3

270

1724

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

6.4

10.3

127

Kela drug reimbursment

Transplant complication

2.1

10.3

110

521

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

10.3

2384

21050

N06AX22

ATC

agomelatine; oral

2.2

10.3

100

455

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

10.2

249

1561

D10

ICPC

Vomiting

1.7

10.2

222

1349

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

2.5

10.2

292

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

10.2

373

2571

D05BB02

ATC

acitretin; oral

1.8

10.2

157

860

E87.2

ICD-10 Finland

Acidosis

3.5

10.1

128

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

10.1

461

3315

F45.0

ICD-10 Finland

Somatization disorder

3.9

10.1

103

R01AD01

ATC

beclometasone; nasal

1.3

10.1

887

7059

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.6

10.1

123

F60.0

ICD-10 Finland

Paranoid personality disorder

4.5

10.1

205

Kela drug reimbursment

Chronic hypertension

1.2

10.1

1964

17061

5188X

ICD-9 Finland

Other diseases of lung

5.2

10.1

SDC10

NOMESCO Finland

Parodontological fixation

2.5

10.1

297

Z72.2

ICD-10 Finland

Drug use

4.7

10.1

98000

ICD-8 Finland

Toxic effect of alcohol, Ethyl alcohol

4.1

10.1

R51

ICD-10 Finland

Headache

1.6

10.1

242

1512

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

10.0

1240

10292

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

2.3

10.0

403

H02BX01

ATC

methylprednisolone, combinations; systemic

1.5

10.0

312

2079

29510

ICD-8 Finland

Schizophrenia, Hebephrenic type

4.5

10.0

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

2.3

10.0

364

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.5

10.0

301

K00.09

ICD-10 Finland

Lack of teeth due to lack of dental development UNS

2.2

10.0

416

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2117

8731

2.82

307.65

2.5

1.7

—

(3019060) Gas panel - Arterial blood

1762

5342

3.80

307.65

5.4

5.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2506

9508

3.20

307.65

9.3

7.6

5.5

5.0

kpa

64.03

2391

9084

(4010399)

1758

5410

3.74

307.65

1.8

1.4

—

(3003396) Base excess in Arterial blood by calculation

2515

9472

3.23

307.65

9.2

7.7

2.1

0.8

mmol/l

40.88

2123

7372

(3027801) Oxygen [Partial pressure] in Arterial blood

2504

9503

3.20

307.65

9.3

7.6

9.8

12.7

kpa

208.77

2383

9069

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1027

2769

4.03

307.65

3.8

2.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1459

4840

3.37

307.65

5.4

3.2

2.7

1.5

mmol/l

24.77

1183

3497

(3009343) pH of Capillary blood

1495

5018

3.34

307.65

5.7

3.3

7.4

0.40

201

628

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2938

12758

2.86

307.65

2.6

1.8

—

(3023368) Bacteria identified in Blood by Culture

4168

22634

2.47

307.65

6.0

4.3

—

(3016502) Oxygen saturation in Arterial blood

2170

8633

2.94

307.65

9.6

8.1

93.1

96.0

57.91

2099

8306

(3023419) Bacteria identified in Sputum by Culture

598

910

6.93

307.65

2.9

2.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1515

5088

3.34

307.65

5.7

3.3

5.5

5.1

kpa

46.15

1443

4686

(3000492) Spirometry study

1905

6984

3.15

307.65

1.9

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1380

4343

3.54

307.65

10.2

10.0

25.2

24.1

mmol/l

26.96

1263

4068

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2104

8741

2.79

307.65

2.6

1.7

—

(42870588) Differential panel, method unspecified - Blood

4348

27325

2.06

254.99

7.3

6.0

—

(3022313) Gas panel - Capillary blood

1093

3664

3.23

253.39

6.0

3.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

509

1011

5.26

242.07

1.2

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1785

8037

2.49

235.62

11.0

8.5

126.5

121.3

g/l

18.15

1732

7741

(3013115) Eosinophils [#/volume] in Blood

5774

40916

2.00

233.95

8.2

6.1

0.2

e9/l

0.84

5192

35673

(3015235) Bicarbonate [Moles/volume] in Capillary blood

723

1950

3.92

233.37

4.8

2.7

26.3

24.4

mmol/l

21.45

654

1697

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3880

24055

2.02

229.68

3.8

2.9

1481.0

1394.2

ng/l

0.47

3412

20669

(3022096) Basophils/100 leukocytes in Blood

5212

35932

1.96

225.34

7.9

6.1

0.6

0.7

10.67

4945

33404

(3019069) Monocytes/100 leukocytes in Blood

5340

37204

1.96

222.85

8.3

6.4

8.6

8.8

5.85

5083

34713

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

614

1522

4.24

222.27

1.7

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

614

1522

4.24

222.27

1.7

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

5310

37013

1.95

220.27

8.0

6.1

2.6

2.9

27.95

5041

34375

(3006315) Basophils [#/volume] in Blood

5590

39670

1.95

219.53

7.7

5.9

0.0

e9/l

23.73

4968

34078

(3005322) IgE [Units/volume] in Serum or Plasma

1117

4107

2.94

219.20

1.5

1.3

342.2

250.5

u/ml

1.44

1042

3778

(3001604) Monocytes [#/volume] in Blood

5562

39467

1.95

217.77

7.7

5.9

0.7

0.6

e9/l

86.32

4935

33899

(3018851) Theophylline [Moles/volume] in Serum or Plasma

126

41.16

208.93

1.9

1.6

41.6

54.1

umol/l

1.16

126

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

392

704

5.76

207.90

4.3

3.5

—

(3002030) Lymphocytes/100 leukocytes in Blood

5369

38083

1.91

205.58

8.1

6.2

24.0

27.6

114.78

5080

35308

(3019198) Lymphocytes [#/volume] in Blood

5629

40555

1.91

205.34

7.8

5.9

1.9

e9/l

0.92

5039

35492

(3028626) Oxygen [Partial pressure] in Capillary blood

620

1640

3.97

205.17

4.4

2.6

7.6

8.2

kpa

15.10

581

1510

(3018010) Neutrophils/100 leukocytes in Blood

5258

37529

1.87

192.25

8.0

6.0

60.9

57.3

95.94

4998

34948

(3000991) Gas panel - Venous blood

1515

6977

2.39

186.75

11.5

8.9

—

(3002032) Base excess in Venous blood by calculation

1587

7512

2.33

183.43

5.0

4.0

2.8

1.7

mmol/l

16.97

1326

6057

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2419

13596

2.04

180.15

4.6

3.5

0.8

mmol/l

17.92

2249

12749

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1576

7528

2.30

177.89

5.0

4.0

6.2

5.8

kpa

37.77

1518

7316

(3012544) pH of Venous blood

1624

7856

2.28

177.88

4.9

4.0

7.4

0.48

(3021901) Oxygen saturation in Capillary blood

530

1389

3.98

177.28

4.1

2.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1541

7339

2.31

174.93

10.3

7.4

1.4

mmol/l

0.34

1471

7062

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1173

4977

2.54

172.04

10.1

7.4

26.2

24.6

mmol/l

26.59

1161

4942

(3013650) Neutrophils [#/volume] in Blood by Automated count

6017

45836

1.81

167.44

12.0

9.3

5.0

4.1

e9/l

135.88

5417

39860

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1204

5256

2.47

165.85

10.2

7.2

25.9

24.4

mmol/l

25.58

1135

4882

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5061

36831

1.77

162.53

9.5

6.3

1.2

mmol/l

21.28

4678

33393

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5682

42793

1.78

161.77

7.6

6.6

10.5

12.0

umol/l

11.81

5417

40683

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

864

3252

2.82

160.45

6.3

3.5

25.3

24.7

mmol/l

8.00

820

2970

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

589

1779

3.46

159.57

1.9

1.5

—

(3042631) Mycobacterium sp identified in Specimen

432

1115

4.01

147.30

3.6

2.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1931

10685

2.01

146.37

11.2

7.3

103.2

104.6

mmol/l

25.36

1859

10486

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

593

1910

3.24

144.65

2.0

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

487

1405

3.60

141.32

1.9

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2696

16819

1.83

141.13

2.1

1.7

1.2

1.3

mg/l

1.26

2133

12979

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1062

4696

2.42

141.07

2.2

1.6

—

(3042936) Bacteria identified in Isolate by Culture

2064

11828

1.94

140.69

2.5

2.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5345

40458

1.71

140.68

9.9

7.1

1.2

mmol/l

27.60

4593

34107

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

921

3834

2.55

139.30

4.9

4.5

24.7

24.0

mmol/l

6.17

824

3431

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

572

1853

3.22

138.10

2.1

1.7

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1166

5465

2.29

135.18

13.0

9.5

91.1

94.2

37.55

1161

5448

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1159

5422

2.29

134.96

12.9

9.3

1.9

1.3

29.47

1152

5386

(1616796) Gas panel - Central venous blood

553

1780

3.23

134.89

5.4

3.5

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1156

5416

2.29

134.09

13.0

9.5

0.6

0.7

6.60

1148

5380

(3032080) INR in Blood by Coagulation assay

4713

34805

1.68

133.27

11.6

9.3

1.2

1.3

inr

2.36

1334

9751

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1374

6930

2.14

132.69

3.7

2.7

236.0

199.3

ng/l

1.58

1252

6306

(3024561) Albumin [Mass/volume] in Serum or Plasma

4766

35354

1.68

132.04

6.0

5.1

33.8

35.4

g/l

62.67

4438

32860

(3006184) Hemoglobin [Mass/volume] in Capillary blood

542

1769

3.18

129.10

2.7

2.1

133.0

129.7

g/l

1.75

353

1267

(3000963) Hemoglobin [Mass/volume] in Blood

8094

88505

0.51

126.77

40.5

21.7

134.9

136.8

g/l

19.64

7983

87221

(3026361) Erythrocytes [#/volume] in Blood

8093

88490

0.51

126.44

40.2

21.6

4.5

e12/l

9.74

7897

85871

(3024731) MCV [Entitic volume]

8094

88484

0.51

125.86

40.0

21.5

92.1

91.3

37.30

7985

87200

(3035941) MCH [Entitic mass]

8093

88476

0.51

125.84

40.0

21.5

30.5

0.39

7984

87192

(3010813) Leukocytes [#/volume] in Blood

8097

88501

0.51

125.63

40.3

21.6

8.0

6.7

e9/l

307.65

7903

85870

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

1107

3.74

124.85

2.0

1.4

—

(3007461) Platelets [#/volume] in Blood

8091

88435

0.51

124.72

40.2

21.6

261.9

243.4

e9/l

91.69

7928

86097

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2543

16106

1.78

123.77

5.3

3.7

418.1

565.4

ng/l

0.83

2067

12958

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1027

4727

2.31

123.73

13.2

10.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

983

4533

2.30

117.64

1.8

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3642

25777

1.66

116.40

3.4

2.6

55.0

59.0

u/l

3.06

3347

23829

(3013826) Glucose [Moles/volume] in Serum or Plasma

6051

48616

1.64

115.54

8.6

4.8

6.9

6.8

mmol/l

3.10

5760

45727

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

210

364

5.87

115.35

4.3

3.7

—

(4015189)

149

178

8.48

115.15

2.9

2.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1663

9427

1.92

114.54

2.1

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

1205

6142

2.10

111.97

4.5

3.2

4.8

4.6

kpa

1.63

1144

5946

(3020779) Urea [Moles/volume] in Serum or Plasma

1435

7860

1.97

108.96

8.9

7.8

10.0

10.2

mmol/l

0.61

1372

7508

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1842

11021

1.83

106.25

7.1

6.3

1.1

1.0

mmol/l

5.74

1728

10297

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

403

1240

3.35

105.50

1.6

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

432

1389

3.21

105.25

2.1

1.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4233

31749

1.59

102.82

5.4

3.5

63.3

76.9

ng/l

0.20

3248

22785

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

364

1067

3.50

102.81

1.1

1.5

g/l

0.18

332

963

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

196

355

5.61

102.78

15.7

17.6

1484.9

1411.8

nmol/l

0.51

185

346

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7356

81938

0.59

101.47

5.6

5.2

2.5

2.7

mmol/l

69.69

6670

75435

(3024891) Influenza virus A+B Ag [Presence] in Specimen

489

1730

2.92

100.86

1.4

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1591

9240

1.86

100.44

2.3

1.8

1.5

22.26

1327

7999

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3631

26375

1.60

100.36

4.2

3.3

37.1

35.8

u/l

0.21

3419

24947

(3027315) Oxygen [Partial pressure] in Blood

508

1859

2.83

98.41

6.9

3.9

8.1

8.7

kpa

10.17

497

1821

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

695

2969

2.44

98.39

2.8

2.3

435.7

685.8

ug/l

1.33

655

2805

(3010421) pH of Blood

556

2138

2.70

97.92

7.0

3.9

7.4

1.22

493

1812

(3013290) Carbon dioxide [Partial pressure] in Blood

503

1847

2.82

96.80

6.9

3.9

5.3

4.9

kpa

17.59

492

1810

(3012501) Base excess in Blood by calculation

503

1847

2.82

96.80

6.9

3.9

3.1

2.4

mmol/l

5.40

405

1217

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7194

80369

0.60

95.78

5.1

4.7

4.4

4.6

mmol/l

56.19

6542

74454

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1096

5721

2.03

94.56

1.8

1.7

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7134

79788

0.61

93.94

5.0

4.6

1.4

mmol/l

33.44

6443

73428

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

353

1087

3.33

92.22

2.2

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

352

1095

3.30

90.45

1.6

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

180

341

5.36

89.89

10.9

12.7

852.2

848.3

nmol/l

0.03

173

323

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

202

426

4.82

89.17

1.6

1.3

2.1

1.2

u/ml

0.73

129

194

(3000494) Fungus identified in Specimen by Culture

1593

9586

1.79

88.49

2.0

1.4

—

(3019977) pH of Arterial blood

197

412

4.86

87.83

2.5

2.8

7.4

1.24

134

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

350

1107

3.24

87.52

1.8

1.9

25.2

24.4

ug/l

0.07

342

1079

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

745

3452

2.25

87.22

2.3

2.0

1.9

2.3

ug/l

0.49

682

3070

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

304

884

3.52

86.87

2.4

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

461

1720

2.76

85.95

3.6

2.4

16.3

16.4

0.15

272

878

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1359

7860

1.85

85.81

2.3

0.2

g/l

0.07

1249

7332

(3009466) Valproate [Moles/volume] in Serum or Plasma

343

1089

3.23

85.22

5.9

4.7

362.0

361.3

umol/l

0.03

301

921

(44790049)

292

861

3.46

81.66

2.3

1.4

—

(44806118)

292

861

3.46

81.66

2.3

1.4

—

(44790047)

292

861

3.46

81.66

2.3

1.4

—

(44790048)

292

861

3.46

81.66

2.3

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1200

6784

1.88

81.14

2.6

2.3

351.0

371.6

nmol/l

2.19

1082

6272

(3028707) Methadone [Presence] in Urine by Screen method

249

665

3.82

80.71

3.1

2.2

—

(3020891) Body temperature

711

3368

2.20

78.63

7.6

4.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

708

3351

2.20

78.45

2.6

1.9

—

(3018418) pH of Serum or Plasma

3231

23890

1.53

77.16

5.2

4.3

7.4

0.35

664

4598

(3023183) Ammonium ion [Moles/volume] in Plasma

471

1876

2.59

77.04

2.5

2.9

33.9

35.0

umol/l

0.40

400

1583

(3018405) Lactate [Moles/volume] in Arterial blood

649

2991

2.25

76.73

6.4

4.1

1.4

mmol/l

0.04

639

2944

(40758558) Short blood count panel - Blood

2809

20224

1.55

75.48

8.8

7.0

—

(3026008) Bacteria identified in Urine by Culture

3008

22008

1.53

74.95

3.8

3.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7931

85727

0.60

74.76

15.4

10.8

27.3

27.5

u/l

0.28

7688

82634

(3026782) Osmolality of Urine

2322

16137

1.58

72.48

3.4

2.8

516.1

562.5

mosm/kgh2o

18.74

2000

13763

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

651

3075

2.20

72.36

2.4

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6958

77236

0.66

70.67

4.5

4.2

1.5

1.3

mmol/l

45.77

6227

70562

(3005719) IgG [Mass/volume] in Serum or Plasma

1055

5972

1.86

70.47

2.9

2.8

9.9

10.6

g/l

7.70

979

5448

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2716

19660

1.53

70.16

2.6

2.2

3.3

2.9

mg/l

7.18

2351

16776

(3047181) Lactate [Moles/volume] in Blood

576

2643

2.25

68.67

7.7

6.5

1.3

mmol/l

0.20

523

2313

(1761868) Lipid panel - Serum or Plasma

2003

28209

0.64

68.10

3.4

3.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

200

519

3.91

67.53

1.3

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

864

4657

1.94

66.93

1.9

1.2

1.3

g/l

1.34

791

4217

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

222

624

3.62

66.78

2.6

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

139

275

5.11

66.15

2.2

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2167

15105

1.56

65.77

1.9

1.7

1101.6

1163.9

nmol/l

2.48

1613

11480

(3022948) Iron [Moles/volume] in Serum or Plasma

1906

12903

1.59

65.67

3.0

2.6

11.5

13.2

umol/l

15.98

1774

11997

(3009445) Proteinase 3 Ab [Units/volume] in Serum

697

3522

2.05

64.82

1.3

1.6

5.7

17.0

u/ml

2.68

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3345

25631

1.46

63.93

2.8

2.2

258.5

214.9

u/l

1.30

3141

24012

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1692

11251

1.61

62.49

3.2

2.7

19.9

23.4

16.91

1451

9591

(3017569) Oxygen content in Arterial blood

155

359

4.37

60.98

2.3

2.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

335

1268

2.70

60.61

2.4

1.8

1.6

1.8

mmol/l

3.91

328

1235

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1774

12011

1.58

60.50

3.0

2.6

2.3

g/l

3.26

1640

11154

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1573

22897

0.63

60.22

2.8

3.0

0.7

0.8

ug/l

1.71

1069

15607

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2376

31631

0.67

59.06

3.9

4.3

20.5

21.9

4.18

1022

15893

(46235355) HIV 1 and 2 tests - Meaningful Use set

1492

9783

1.62

57.96

1.7

—

(3043409) Potassium [Moles/volume] in Arterial blood

535

2560

2.15

57.31

7.1

4.3

4.0

3.9

mmol/l

2.11

491

2424

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1897

13239

1.54

56.03

2.4

2.1

30.5

30.0

2.10

1845

12869

(3027273) Bicarbonate [Moles/volume] in Venous blood

730

3952

1.92

55.47

4.8

3.5

26.3

25.0

mmol/l

13.25

711

3830

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1195

7516

1.67

54.49

3.2

2.5

32.5

55.1

u/l

1.33

1006

6472

(3000850) Epithelial cells [#/volume] in Urine

2382

17514

1.48

54.44

3.4

2.6

6.1

4.4

e6/l

6.67

2104

15341

(3022217) INR in Platelet poor plasma by Coagulation assay

1673

11466

1.55

53.34

24.7

25.3

1.3

1.4

inr

0.61

251

1654

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

478

2269

2.16

52.21

1.3

—

(3003181) Sodium [Moles/volume] in Urine

330

1339

2.52

51.82

1.5

1.3

53.1

65.7

mmol/l

6.01

230

1067

(3022806) Fractional oxyhemoglobin in Capillary blood

277

1031

2.74

51.78

2.3

1.8

88.5

89.5

2.26

272

1017

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

7.83

50.95

3.3

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

579

2984

2.00

50.71

3.5

3.1

0.3

u/ml

2.25

340

1712

(3002582) Erythrocytes [#/volume] in Urine

3216

25260

1.41

50.57

4.3

3.3

55.8

93.9

e6/l

2.53

2557

19563

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1467

9874

1.57

50.39

3.6

4.6

240.7

245.1

u/l

0.45

1377

9357

(3033658) Prothrombin time (PT) actual/Normal

2761

21137

1.43

50.13

6.0

4.0

88.8

88.1

0.67

2677

20644

(3011288) Drugs identified in Urine by Screen method

260

960

2.75

49.37

3.3

2.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

297

1179

2.57

48.82

3.0

1.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

855

5053

1.76

48.68

4.7

3.4

129.7

129.4

g/l

0.15

832

4922

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1407

9459

1.57

48.42

2.7

2.9

9.3

umol/l

0.02

1176

8374

(3020191) Ethanol [Moles/volume] in Serum or Plasma

204

668

3.10

48.15

1.6

1.3

1.5

1.4

promille

0.50

160

508

(3017181) Myelocytes/100 leukocytes in Blood

1102

7006

1.65

47.80

4.4

4.1

1.0

0.16

367

2067

(4198724)

104

215

4.88

47.11

1.9

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1412

9583

1.55

46.43

2.7

2.5

1.9

1.8

6.05

1244

8529

(3003338) MCHC [Mass/volume]

5974

66720

0.73

46.02

37.2

18.8

330.0

333.0

g/l

102.29

5901

66264

(3052851) Hemolysis interference index of Serum or Plasma

484

2423

2.05

45.90

4.6

3.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

532

2759

1.98

45.70

1.6

130.9

282.0

titre

1.74

106

(3024980) IgG subclass 4 [Mass/volume] in Serum

300

1244

2.46

44.97

1.7

1.6

0.7

0.9

g/l

1.74

226

925

(3002179) Metamyelocytes/100 leukocytes in Blood

1007

6363

1.65

44.59

4.0

3.9

0.8

0.7

0.22

264

1499

(3016879) Cocaine [Presence] in Urine

329

1428

2.35

44.55

3.0

1.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

218

775

2.85

44.48

1.6

1.4

2.5

3.0

g/l

3.20

154

525

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7317

78998

0.71

44.31

5.6

4.8

6.3

6.0

mmol/l

35.44

6590

71959

(3031040) Bacteria [#/volume] in Urine by Automated count

5898

51688

1.36

44.30

5.9

4.3

1245.7

1008.5

e6/l

0.12

114

759

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

194

648

3.03

44.27

1.9

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

217

775

2.84

43.90

1.6

1.4

0.4

g/l

0.10

155

526

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

124

312

4.01

43.80

2.3

1.8

124.6

119.0

umol/l

0.08

153

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

627

3483

1.85

43.75

6.8

5.5

2.3

1.6

18.50

593

3244

(3027135) IgG subclass 1 [Mass/volume] in Serum

217

777

2.83

43.69

1.6

1.4

6.2

6.9

g/l

2.32

153

527

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

3666

29993

1.36

42.90

4.3

3.4

—

0.4

—

(4062490)

215

777

2.81

42.56

1.6

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

302

6495

0.45

42.29

1.7

1.9

—

(40761511) CBC panel - Blood by Automated count

7765

82842

0.70

41.99

25.4

13.9

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

142

5.60

41.88

4.5

1.9

—

(36304419) Bacteria [Presence] in Urine

2830

22314

1.38

41.54

4.1

3.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

201

710

2.87

41.52

1.5

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

201

710

2.87

41.52

1.5

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

201

710

2.87

41.52

1.5

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

2925

23202

1.37

41.31

4.2

3.2

0.6

0.4

e6/l

2.52

2277

17549

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6987

63151

1.37

41.29

10.6

7.8

82.7

79.1

u/l

5.71

6660

59460

(3024928) Oxygen saturation in Venous blood

371

1752

2.16

41.01

3.9

3.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

1025

6643

1.61

40.78

4.5

4.1

0.1

0.53

342

1910

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

153

467

3.31

40.62

1.9

1.5

—

(21494755) Public health laboratory ask at order entry panel

294

6294

0.45

40.60

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

317

1411

2.29

40.50

3.3

2.9

0.8

nmol/l

0.53

251

1051

(3015377) Calcium [Moles/volume] in Serum or Plasma

3298

26721

1.35

40.46

3.6

2.3

2.4

mmol/l

0.30

2840

23319

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3263

39455

0.74

40.42

4.3

5.0

3.4

3.3

ug/l

0.02

2806

35551

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

4012

33505

1.33

40.04

2.2

2.0

90.2

94.7

pmol/l

8.02

2299

17879

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

441

2250

2.01

39.64

1.4

10.3

14.6

iu/ml

—

(3000764) Benzodiazepines [Presence] in Urine

335

1540

2.22

39.60

3.0

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

211

790

2.71

39.06

2.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

150

465

3.26

38.86

1.9

1.5

—

(3028300) Cannabinoids [Presence] in Urine

335

1555

2.20

38.67

3.1

1.7

—

(3027008) Opiates [Presence] in Urine

334

1550

2.20

38.58

3.0

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

163

534

3.09

38.51

1.8

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1848

13696

1.43

38.50

1.6

1.5

2.7

2.6

g/l

1.00

1134

8345

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1136

7638

1.55

38.44

2.8

2.3

8.1

8.0

ug/l

0.01

993

6750

(3039000) Anion gap in Blood

389

1921

2.07

38.25

8.2

7.7

10.9

11.3

mmol/l

1.76

360

1713

(3018572) Chloride [Moles/volume] in Blood

389

1922

2.07

38.20

8.2

7.7

104.0

105.4

mmol/l

5.67

360

1714

(3018095) Leukocytes [#/volume] in Urine

3499

28807

1.33

37.87

5.0

3.7

89.2

89.8

e6/l

0.02

2654

20975

(40757373) Influenza virus identified in Isolate

149

5.20

37.69

2.4

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

597

3418

1.80

37.64

7.0

5.6

0.9

1.01

564

3188

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

218

846

2.61

37.59

2.0

1.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

646

3793

1.75

37.35

4.6

2.8

0.6

0.7

0.77

623

3630

(3025159) Blasts/100 leukocytes in Blood

950

6232

1.58

35.68

4.6

4.1

0.0

0.3

1.64

287

1614

(3008536) Aspergillus sp Ab [Presence] in Serum

157

4.94

35.52

1.6

2.4

—

(3027944) Amphetamines [Presence] in Urine

322

1523

2.15

35.46

3.2

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

621

3683

1.73

34.61

5.9

3.9

52.2

48.3

3.59

612

3639

(3037522) Nuclear Ab [Titer] in Serum

1415

10175

1.46

34.28

1.4

1.3

481.9

511.6

titre

0.26

318

2069

(40760892) CBC W Ordered Manual Differential panel - Blood

2195

17073

1.37

33.77

5.7

4.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

216

885

2.47

33.30

38.4

6.7

8.2

7.4

mmol/l

0.67

184

714

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

329

1609

2.08

33.22

1.2

32.0

210.0

titre

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1226

8637

1.48

32.90

4.7

3.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1117

7733

1.50

32.66

1.7

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

7978

84151

0.72

32.36

33.4

17.1

4.0

mmol/l

7.89

7818

82042

(3021960) Folate [Moles/volume] in Serum or Plasma

2369

18794

1.34

31.72

1.7

1.5

18.6

20.2

nmol/l

5.20

2058

16080

(3013707) Erythrocyte sedimentation rate by Westergren method

6506

59112

1.30

31.11

5.7

4.0

16.2

12.3

mm/h

58.36

6053

54535

(3020630) Protein [Mass/volume] in Serum or Plasma

1038

7158

1.50

30.84

2.0

2.6

65.1

66.5

g/l

6.85

955

6525

(3009508) Creatinine [Moles/volume] in Urine

3283

27411

1.30

30.17

3.5

3.2

7.2

7.9

mmol/l

16.93

2671

22958

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

426

2354

1.85

30.12

2.7

2.6

3.8

3.6

g/l

1.94

399

2242

(3019550) Sodium [Moles/volume] in Serum or Plasma

7971

83929

0.73

29.86

33.4

16.9

139.0

139.7

mmol/l

97.95

7818

81954

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

180

4104

0.43

29.04

1.4

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

3104

25824

1.30

29.03

3.0

2.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

163

626

2.63

28.80

1.6

1.4

11.8

12.8

u/l

1.21

158

604

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

143

518

2.79

28.31

2.5

1.8

—

(3021589) Normoblasts [#/volume] in Blood

4091

35396

1.27

27.50

14.0

9.8

0.0

e9/l

1.33

3371

29031

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1860

14499

1.35

27.40

3.3

3.2

2.5

mmol/l

19.87

1586

12745

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

264

1279

2.09

27.38

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

447

2581

1.77

27.32

1.9

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1734

13386

1.36

27.19

3.7

3.0

2.6

1.8

e6/l

3.40

996

7423

(3020682) Albumin/Creatinine [Ratio] in Urine

3305

27919

1.28

26.87

4.2

4.0

15.8

8.8

mg/mmol

6.30

2149

17992

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

228

3.71

26.81

3.3

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

228

3.71

26.81

3.3

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1174

8507

1.43

26.81

1.7

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7183

76525

0.77

26.80

24.9

13.8

81.9

79.0

ml/min/173m2

22.98

6187

63608

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

251

1208

2.11

26.50

6.2

6.6

11.6

mg/l

0.01

227

1120

(40768797) Stomach Pathology biopsy report

1500

11362

1.38

26.44

1.4

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

116

391

2.99

26.22

2.2

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3629

31134

1.26

25.60

3.4

2.8

145.2

161.8

ug/l

2.48

3317

28632

(3042733) HLA Ab [Presence] in Serum

290

3.30

25.37

4.6

5.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

422

2451

1.75

25.28

1.5

1.4

267.7

267.5

ug/g

0.01

255

1451

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

121

427

2.86

25.20

1.5

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

121

427

2.86

25.20

1.5

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

121

427

2.86

25.20

1.5

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

121

427

2.86

25.20

1.5

2.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

240

1164

2.09

24.85

1.4

1.5

35.5

32.8

g/l

2.56

210

1050

(3008757) Leukocyte morphology finding [Identifier] in Blood

201

909

2.24

24.84

3.2

4.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

217

3.66

24.81

2.6

1.4

—

(3016038) Potassium [Moles/volume] in Urine

132

492

2.71

24.80

1.2

31.6

34.6

mmol/l

0.82

110

425

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

321

1728

1.89

24.67

11.7

5.4

350.0

2113.2

iu/ml

1.08

262

(3037467) Urinalysis macro (dipstick) panel - Urine

6003

54675

1.25

24.59

5.6

4.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2428

19907

1.29

24.52

3.0

2.4

—

(3051651) Icteric interference index of Serum or Plasma

131

491

2.69

24.35

5.0

4.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

217

1023

2.15

24.20

1.4

1.5

5475.0

2040.4

e6/l

1.00

161

731

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

7.58

24.17

1.4

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

1015

7315

1.43

23.73

2.5

2.6

75.6

69.0

e9/l

6.11

755

5615

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

417

2460

1.73

23.64

2.7

2.2

90.2

89.5

0.26

396

2300

(3012516) Albumin [Mass/volume] in Urine

3125

26558

1.26

23.29

3.4

3.3

385.7

378.2

mg/l

0.03

2084

17103

(3019225) pH of Specimen

1115

8234

1.40

22.65

4.4

4.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

310

1697

1.85

22.63

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

270

1419

1.93

22.35

2.6

3.5

1.2

1.6

1.06

207

1095

(3012441) Differential panel - Pleural fluid

191

884

2.18

22.35

1.4

1.5

—

(3036489) Thrombin time

477

2972

1.64

21.99

2.6

2.1

21.3

21.6

0.40

422

2614

(3039443) Prostate specific Ag panel - Serum or Plasma

2212

0.33

21.97

1.5

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

376

2204

1.73

21.82

1.6

0.2

g/l

0.04

352

2083

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1193

8962

1.38

21.81

3.1

4.4

22.0

25.1

ug/l

0.18

1058

7396

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3596

31215

1.24

21.80

2.6

2.2

73.6

77.7

nmol/l

13.24

3183

27987

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7167

75843

0.79

20.94

7.6

6.1

42.2

40.3

mmol/mol

46.67

6543

70052

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

383

2284

1.70

20.90

1.6

1.2

g/l

0.34

360

2167

(3028308) Erythrocytes [#/volume] in Pleural fluid

193

927

2.10

20.57

1.4

1.5

95454.2

60275.3

e6/l

0.33

120

542

(44816559) Phosphatidylethanol [Mass/volume] in Blood

252

1334

1.91

20.44

1.6

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

207

1025

2.04

20.34

1.5

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

373

2233

1.70

20.07

2.9

2.5

208.6

197.9

1.43

351

2122

(3001019) Free T4 and TSH panel - Serum or Plasma

147

3128

0.46

19.74

1.5

1.7

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

359

2.78

19.70

14.7

12.1

0.6

mmol/l

0.22

329

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

172

806

2.15

19.56

1.3

789.6

448.5

u/l

0.44

165

764

(3010726) Horse dander IgE Ab [Units/volume] in Serum

169

798

2.14

18.87

1.1

1.0

2.4

1.6

u/ml

0.52

181

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

113

4.26

18.71

1.3

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5702

52353

1.21

18.70

4.6

3.2

70.3

53.5

u/l

16.17

5288

48504

(40768806) Pleura Pathology biopsy report

185

911

2.05

18.50

1.5

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

576

3900

1.51

18.46

1.6

1.7

1.5

g/l

4.24

496

3330

(3035637) Corticotropin [Mass/volume] in Plasma

197

995

2.00

18.37

1.6

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

176

855

2.08

18.26

4.8

3.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

244

1330

1.86

18.13

4.8

2.6

581.0

7535.8

u/ml

0.60

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

142

636

2.25

18.09

1.2

1.3

13.7

12.8

u/l

0.17

132

589

(3009542) Hematocrit [Volume Fraction] of Blood

6745

71533

0.82

17.96

30.0

15.7

39.5

40.0

3.25

4267

49778

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

159

749

2.14

17.88

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

514

3421

1.53

17.87

2.0

1.9

38.6

39.1

u/l

0.25

438

2992

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

822

6000

1.40

17.71

4.5

4.1

103.6

94.1

ng/l

1.53

704

5206

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

118

493

2.41

17.65

1.7

2.8

0.2

e9/l

0.03

433

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1766

14417

1.27

17.60

3.5

2.8

1.2

1.0

e6/l

0.79

1030

8392

(3008295) Osmolality of Serum or Plasma

165

795

2.09

17.51

1.3

1.4

272.9

280.5

mosm/kgh2o

2.86

124

637

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

332

2.73

17.39

1.6

2.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.37

17.36

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

711

5080

1.43

17.28

1.5

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

354

2178

1.65

17.20

2.1

2.0

11.4

11.6

mg/l

0.16

331

2021

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

121

518

2.35

17.15

1.7

2.7

595.3

522.2

e6/l

0.85

435

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

191

979

1.97

17.11

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

363

2253

1.63

17.04

1.6

2.6

6.7

iu/ml

0.52

498

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

330

2.71

17.03

1.6

2.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

330

2.71

17.03

1.6

2.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

293

2.81

16.84

1.0

1.1

5.9

4.2

u/ml

0.34

(3017354) Segmented neutrophils/100 leukocytes in Blood

174

868

2.02

16.83

2.4

3.5

62.9

57.9

2.11

109

561

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

308

2.74

16.44

1.6

1.4

1410637.5

1319331.8

iu/ml

—

(3045716) Anion gap in Serum or Plasma

356

2.60

16.21

4.1

2.3

8.7

9.2

mmol/l

0.66

268

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.87

16.14

1.2

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2694

23237

1.22

16.11

3.5

2.7

3187.6

4490.7

umol/l

1.01

2290

20152

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

252

2.91

15.99

2.8

2.4

155.7

146.1

nmol/l

0.40

218

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

272

1597

1.72

15.79

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

272

1598

1.72

15.75

1.5

1.4

17.9

16.1

u/ml

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

101

416

2.44

15.63

2.5

2.8

—

34.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

249

1431

1.76

15.59

1.6

1.5

121.4

115.8

u/ml

0.44

294

(3004588) Protein electrophoresis panel - Serum or Plasma

804

5979

1.38

15.45

1.8

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2066

17407

1.24

15.37

1.8

1.7

52019423.2

31044930.2

pmol/l

0.65

1684

14447

(3024932) HLA-DR beta [Type]

293

2.71

15.16

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

191

1026

1.88

14.94

1.1

1.4

1.5

u/ml

0.05

406

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

290

2.70

14.91

1.2

1.3

—

(3013512) EKG study

2855

24919

1.21

14.86

5.1

3.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

173

903

1.93

14.76

1.0

1.1

5.0

4.5

u/ml

0.13

421

(3036782) Glucose [Moles/volume] in Pleural fluid

156

788

2.00

14.64

1.3

1.4

6.5

6.3

mmol/l

0.30

146

722

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

6.33

14.53

1.4

1.6

0.4

1.2

mg/l

0.67

(3010375) cycloSPORINE [Mass/volume] in Blood

406

2.40

14.53

42.0

25.8

146.3

113.8

ug/l

3.66

334

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

156

3.35

14.44

1.2

—

(3045788) Cell count panel - Pleural fluid

155

789

1.98

14.24

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

167

875

1.92

14.11

1.0

1.1

0.9

1.2

u/ml

0.27

358

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

0.9

0.6

mg/l

0.22

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

4.1

1.9

mg/l

0.81

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

3.0

1.0

mg/l

0.73

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

0.9

0.7

mg/l

0.12

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

1.7

1.5

mg/l

0.07

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

2.3

1.9

mg/l

0.11

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

1.8

2.5

mg/l

0.24

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

0.7

1.4

mg/l

0.51

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

6.40

14.08

1.4

1.6

2.3

3.2

mg/l

0.32

(3024471) HLA-A [Type]

299

2.62

14.06

1.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

463

3172

1.48

14.04

2.0

2.4

3.3

3.0

g/l

7.41

364

2474

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

188

1026

1.85

14.02

2.5

1.9

28.3

26.6

mg/l

0.14

263

(3048929) Epstein Barr virus Ab [Presence] in Serum

314

1978

1.61

13.94

1.1

1.2

—

(3011412) CD3 cells [#/volume] in Blood

149

760

1.98

13.63

1.7

2.5

1.2

1.1

e9/l

0.27

464

(4306422)

198

1108

1.80

13.62

1.3

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

193

1076

1.81

13.45

1.2

1.1

113.9

117.5

0.77

179

959

(40768800) Prostate Pathology biopsy report

138

2627

0.52

13.41

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

123

590

2.10

13.33

1.8

2.6

915.0

617.7

e6/l

2.34

232

(3023430) Cat dander IgE Ab [Units/volume] in Serum

129

636

2.04

13.00

1.1

1.0

7.4

2.8

u/ml

1.29

243

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

484

3396

1.45

12.99

2.0

2.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

390

2622

1.51

12.99

2.1

2.3

36.2

37.9

g/l

5.94

343

2255

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

484

3401

1.45

12.89

2.0

2.4

7.9

7.3

g/l

10.06

370

2529

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

380

2545

1.51

12.89

2.2

2.3

0.1

0.0

g/l

0.41

354

2304

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

482

3391

1.44

12.76

2.0

2.4

4.1

3.8

g/l

1.18

361

2424

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

420

2881

1.48

12.68

2.1

2.5

0.6

1.0

g/l

1.19

368

2462

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

357

2369

1.53

12.65

2.2

2.4

0.0

g/l

0.35

331

2134

(3017732) Neutrophils [#/volume] in Blood

733

5551

1.35

12.51

3.8

2.9

4.9

4.1

e9/l

11.88

524

4270

(3007566) Smooth muscle Ab [Titer] in Serum

340

2238

1.54

12.51

1.2

125.0

144.8

titre

0.15

194

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

351

2328

1.53

12.47

2.2

2.4

0.0

g/l

0.00

328

2126

(40757494) Bilirubin.total [Moles/volume] in Blood

102

468

2.19

12.41

2.5

2.3

14.5

39.6

umol/l

1.20

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

864

6721

1.31

12.24

5.1

4.1

1.2

mmol/l

5.30

786

5903

(3035880) pH of Pleural fluid

103

478

2.17

12.19

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

450

3155

1.45

12.14

2.0

2.4

9.5

10.3

g/l

3.80

382

2665

(3042517) Benzodiazepines panel - Urine

6.01

12.11

4.7

2.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

411

2835

1.47

12.08

1.3

1.2

0.5

1.0

u/ml

0.85

263

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

318

2082

1.55

12.00

1.4

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

334

2212

1.53

11.97

1.2

683.8

915.9

titre

0.50

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

242

1493

1.64

11.76

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

133

690

1.94

11.66

1.1

1.0

6.9

3.4

u/ml

1.10

260

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

193

1125

1.73

11.61

1.3

1.2

3.0

4.1

u/ml

1.57

478

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

192

1120

1.73

11.53

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

150

815

1.85

11.43

2.5

3.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

445

2.17

11.42

1.6

1.3

—

(3006245) CD3-CD19+ cells/100 cells in Blood

266

2.53

11.33

1.5

2.3

10.2

11.3

0.39

237

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

227

1393

1.64

11.28

1.2

1.3

316.5

286.3

u/ml

0.64

148

865

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

194

1145

1.71

11.18

1.3

1.2

2.3

3.6

u/ml

1.34

364

(3006576) Bicarbonate [Moles/volume] in Blood

324

2.36

11.04

5.4

6.9

26.4

25.1

mmol/l

1.53

290

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

294

1935

1.54

10.88

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1516

12776

1.22

10.85

1.3

52.0

35.0

iu/ml

2.52

494

3968

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1791

15345

1.20

10.81

1.3

1.2

1.6

1.9

u/ml

0.48

415

4106

(3000060) B lymphocytes [#/volume] in Blood

175

2.87

10.81

1.4

2.3

195.2

657.6

e6/l

0.57

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

149

823

1.82

10.80

1.2

1.1

93.8

97.8

1.20

139

761

(3014271) Vancomycin [Susceptibility]

410

2.16

10.38

3.1

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

270

1771

1.54

10.17

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

636

8224

0.76

10.15

1.5

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

376

2.19

10.08

1.5

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

144

2.99

10.07

1.2

1.4

—

(3028433) Virus identified in Specimen by Culture

278

2.38

9.89

1.3

1.1

—

(3037756) Immunofixation for Serum or Plasma

280

1870

1.51

9.72

1.3

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

383

2.15

9.64

36.1

33.6

8.1

7.3

ug/l

2.67

348

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

221

1403

1.59

9.63

1.3

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

4.43

9.53

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1804

0.52

9.49

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

1024

1.68

9.41

1.4

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

6230

65370

0.87

9.41

33.8

17.8

14.3

13.7

151.43

6115

63947

(3005988) Vibrio sp identified in Specimen by Organism specific culture

171

1027

1.68

9.32

1.4

1.5

—

(3011648) Oxygen content in Venous blood

120

652

1.85

9.24

2.5

2.3

11.1

11.3

0.18

120

652

(21494815) CD4 cells/100 lymphocytes in Specimen

125

688

1.83

9.24

1.7

2.3

36.9

41.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

1022

1.68

9.23

1.4

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

107

561

1.92

9.19

1.6

2.1

—

(3048689) Calprotectin [Mass/mass] in Stool

1039

8567

1.24

9.10

2.3

2.2

204.6

146.1

ug/g

1.55

814

6783

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

522

1.94

9.06

1.3

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

108

571

1.90

9.06

1.1

1.0

0.6

0.2

u/ml

0.96

134

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

174

1059

1.65

9.02

1.4

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

103

537

1.93

9.01

1.3

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

304

2.25

8.93

2.7

1.8

557.8

26956.5

u/ml

0.88

(42529406) Shigella sp [Presence] in Stool by Culture

308

2138

1.45

8.86

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

306

2127

1.45

8.74

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

194

1227

1.59

8.64

1.9

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

131

748

1.76

8.60

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

107

578

1.86

8.43

1.5

1.6

16.5

25.3

u/ml

2.13

127

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

218

1429

1.54

8.32

1.4

1.3

31.9

36.9

u/l

0.34

185

1229

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

168

1036

1.63

8.31

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

263

2.29

8.29

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

550

4247

1.31

8.25

3.2

3.4

4.3

4.4

pmol/l

2.97

481

3777

(40761536) Microorganisms panel - Urine sediment

818

6641

1.25

8.23

4.8

3.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

168

1040

1.63

8.19

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

301

2114

1.44

8.17

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

160

980

1.64

8.14

1.2

1.3

—

nmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4719

44209

1.13

8.07

3.2

2.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

629

7908

0.78

8.05

2.5

2.2

12.4

12.8

nmol/l

0.68

532

7006

(3000093) Morphology [Interpretation] in Blood Narrative

135

793

1.71

8.05

1.1

—

(3015736) pH of Urine

3257

29814

1.14

8.04

4.0

3.3

—

5.7

—

(3009871) Measles virus Ab [Titer] in Serum

248

2.31

8.02

1.4

1.7

—

(36660697) Celiac disease serology panel - Serum

692

5529

1.27

7.98

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

132

773

1.72

7.96

2.2

2.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

115

648

1.78

7.93

1.2

218.0

161.1

titre

0.28

114

(3000475) Leukocytes [#/volume] in Synovial fluid

298

2101

1.43

7.93

1.6

12653.3

13676.6

e6/l

0.17

225

1518

(3011985) Renin [Units/volume] in Plasma

178

1128

1.59

7.90

1.3

1.4

87.6

62.1

mu/l

0.74

157

1000

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

512

1.88

7.90

1.2

1.3

746.3

340.3

titre

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

316

2254

1.42

7.88

2.0

1.7

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.43

7.88

8.8

7.6

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

106

584

1.82

7.88

1.5

2.1

12.3

15.2

1.95

237

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

492

1.90

7.85

1.2

1.3

62.0

titre

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

135

801

1.69

7.78

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

440

1.94

7.66

1.5

1.2

186.1

415.1

u/l

2.13

403

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

175

1116

1.58

7.58

1.2

1.3

0.6

2.9

nmol/l

0.99

164

1074

(1175426) CD3 cells/100 lymphocytes in Blood

107

599

1.80

7.56

1.5

2.1

75.1

71.8

2.15

102

564

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

165

2.55

7.39

2.6

1.7

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

175

1123

1.57

7.39

1.2

1.3

0.1

0.3

nmol/l

1.27

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

214

2.34

7.34

1.3

1.4

29.7

23.9

0.61

178

(3003694) ABO and Rh group [Type] in Blood

1934

21678

0.87

7.26

1.4

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

105

2.96

7.21

1.9

14.7

17.9

umol/l

0.94

105

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

285

2030

1.42

7.20

1.3

65.0

34.6

u/ml

—

117

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

274

2.16

7.15

1.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

142

874

1.63

7.15

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

294

2.12

7.13

1.8

1.5

2.1

2.0

umol/l

0.12

278

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

268

1894

1.43

7.09

1.3

7.0

6.6

u/ml

0.07

299

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

265

1869

1.43

7.08

1.3

10.2

4.2

u/ml

0.80

191

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

164

1055

1.56

6.89

1.2

1.4

228.8

307.0

pmol/l

1.55

115

800

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

423

1.90

6.82

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

328

2.02

6.73

1.6

1.7

3.2

5.2

nmol/l

0.53

273

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4092

38281

1.12

6.69

4.8

4.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

110

2.82

6.66

1.0

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

157

1010

1.56

6.61

1.2

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.44

6.55

1.0

1.3

66.0

42.6

mg/l

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

415

1.89

6.54

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

415

1.89

6.54

1.3

1.5

—

(44813793)

466

1.83

6.50

1.0

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

572

4591

1.26

6.39

3.7

2.8

0.4

0.3

e6/l

0.53

562

4500

(3032057) Clostridioides difficile [Presence] in Stool

178

2.37

6.35

1.8

1.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

249

2.13

6.29

1.2

1.3

180.7

460.7

ug/l

0.92

121

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

310

2295

1.36

6.27

2.9

3.1

1.8

1.6

mg/l

2.84

275

2093

(3035320) C reactive protein [Mass/volume] in Body fluid

545

1.75

6.26

3.5

2.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.66

6.18

1.3

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

258

2.10

6.15

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

504

1.77

6.14

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

326

1.97

6.13

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

245

1757

1.40

6.03

2.2

1.6

0.9

0.8

nmol/l

1.84

187

1463

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

105

627

1.68

6.01

1.0

1.1

304.3

283.0

mg/l

2.10

558

(3004451) EKG impression Narrative

413

1.85

6.01

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

140

2.51

6.00

1.1

5.0

5.9

u/ml

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

242

2.11

5.92

2.0

3.3

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

373

2866

1.31

5.89

2.1

3.4

34.0

48.6

mg/l

1.96

299

2316

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

129

816

1.59

5.89

1.1

1.2

1.8

iu/ml

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.52

5.87

1.3

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

243

2.10

5.86

1.2

1.6

14.0

12.4

g/l

0.69

179

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

506

1.75

5.79

2.2

2.8

39.6

35.4

1.00

173

(3037121) Protein [Mass/volume] in Urine

371

2859

1.31

5.75

3.2

3.4

0.3

g/l

0.22

182

1310

(3004616) Nuclear Ab [Presence] in Serum

147

964

1.53

5.74

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

190

1316

1.45

5.69

1.5

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

314

2368

1.34

5.67

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.97

5.67

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

141

919

1.54

5.67

1.1

1.2

54.6

64.6

u/l

1.16

604

(3034860) Kappa light chains.free [Mass/volume] in Serum

371

2865

1.31

5.67

2.1

3.4

52.3

76.2

mg/l

0.62

293

2315

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1371

12081

1.16

5.65

1.3

23.5

13.0

u/ml

1.57

427

4604

(3034426) Prothrombin time (PT)

267

2.03

5.65

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

185

1277

1.46

5.64

1.1

—

(3025941) Bacteria identified in Stool by Culture

510

4102

1.26

5.64

1.3

—

(3002619) Bacteria identified in Specimen by Culture

157

2.36

5.62

1.2

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

358

1.88

5.61

2.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

127

2.52

5.60

1.1

1.4

178.7

716.8

ng/l

0.46

(3000034) Microalbumin [Mass/volume] in Urine

131

843

1.56

5.58

2.9

3.0

90.9

47.0

mg/l

0.47

615

(3033799) Differential panel - Peritoneal fluid

317

1.93

5.55

2.0

—

(4035726)

873

7431

1.19

5.53

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

105

2.67

5.48

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.06

5.48

1.3

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

399

5050

0.78

5.45

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

456

1.76

5.45

2.3

2.1

45.6

157.5

ug/min

1.33

119

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

190

1331

1.44

5.38

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

110

688

1.61

5.31

1.3

24.7

32.0

u/l

1.53

548

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

187

1311

1.43

5.28

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

359

2790

1.30

5.26

2.1

3.4

31.4

3.6

ratio

0.47

221

(3046861) Legionella sp Ag [Presence] in Urine

3.85

5.25

1.3

1.0

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.71

5.25

3.2

3.3

1.3

mg/l

0.08

(4094501)

178

2520

0.70

5.23

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

783

0.47

5.20

1.3

71.5

104.6

pmol/l

0.34

248

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

163

2.27

5.19

1.8

1.7

—

(3034988) Calcium [Moles/volume] in Capillary blood

145

2.35

5.13

2.5

1.8

1.2

mmol/l

0.66

140

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.72

5.09

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2024

18426

1.12

5.05

4.0

3.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

134

2.39

5.03

11.3

11.9

4.8

5.7

mmol/l

1.40

134

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

363

2850

1.28

4.94

1.1

43.7

8.1

u/ml

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

113

725

1.57

4.93

1.7

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

215

1568

1.38

4.87

1.3

1.2

3.0

4.1

u/ml

0.23

113

(3035947) Staphylolysin Ab [Units/volume] in Serum

405

1.76

4.87

1.2

1.1

4.3

4.2

iu/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

150

2.27

4.78

1.1

0.8

0.7

umol/24h

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

107

684

1.57

4.76

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

483

1.68

4.75

1.4

1.3

1.2

nmol/l

0.36

371

(3041918) Cholesterol [Moles/volume] in Pleural fluid

170

2.18

4.73

1.2

1.7

1.6

mmol/l

0.18

104

(3023511) Choriogonadotropin [Units/volume] in Urine

395

1.75

4.69

1.4

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.64

4.64

1.2

—

mmol/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

115

2.44

4.61

1.2

1.3

37.9

351.7

u/l

0.65

(3023487) Leukocytes [#/volume] in Peritoneal fluid

353

1.79

4.61

1.8

2.3

638.6

3248.3

e6/l

0.64

251

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

413

1.72

4.57

3.1

3.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

223

1655

1.36

4.56

1.9

1.7

46.4

4.4

iu/l

0.49

543

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

197

1434

1.38

4.55

1.3

1.2

44.8

43.8

u/ml

0.03

147

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

190

2592

0.73

4.52

1.8

1.7

9.8

3.6

mg/l

3.75

158

1850

(3007463) Buprenorphine [Presence] in Urine

10.01

4.51

10.4

5.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.86

4.48

3.2

2.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

242

1.95

4.47

1.1

1.3

0.3

g/l

2.14

192

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

104

672

1.55

4.44

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

403

1.72

4.40

1.9

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

2285

21090

1.11

4.39

4.9

4.0

0.0

estimate

3.18

847

6801

(4268621)

115

762

1.52

4.39

2.5

2.3

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

100

2.50

4.36

1.2

1.3

6.2

305755.2

nmol/l

0.72

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

119

796

1.50

4.34

1.5

1.3

1.6

1.4

nmol/l

0.54

112

712

(3042010) Triglyceride [Moles/volume] in Pleural fluid

131

2.29

4.34

1.2

1.3

0.5

1.6

mmol/l

1.42

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

589

1.58

4.34

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

115

765

1.51

4.31

1.3

1.4

24.5

21.8

iu/ml

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

317

1.80

4.30

1.0

1.1

100.3

97.3

0.37

250

(4133840)

225

1.96

4.28

1.4

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

238

1803

1.33

4.27

1.4

9.4

9.7

u/l

0.12

179

1455

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

171

2.11

4.27

1.5

1.6

0.3

0.4

ug/l

0.66

111

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

608

1.57

4.25

1.7

—

(3044927) Protein electrophoresis panel - Urine

128

876

1.47

4.19

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

501

1.62

4.18

1.1

1.3

41.2

23.2

u/l

1.07

421

(40768441) Liver Pathology biopsy report

604

1.56

4.14

1.3

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

4111

39090

1.09

4.13

4.5

3.6

0.0

estimate

0.59

838

6912

(3035350) Ketones [Presence] in Urine by Test strip

4056

38558

1.09

4.08

4.5

3.5

0.0

estimate

0.50

865

7015

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

211

2780

0.75

4.01

1.9

1.7

39.6

42.4

nmol/l

1.00

200

2676

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

422

1.66

4.01

1.1

ratio

0.34

146

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

175

1280

1.37

3.98

1.1

109.0

8623.8

iu/ml

0.54

276

(3044889) 12 lead EKG panel

5666

58636

0.92

3.97

5.1

3.9

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7022

72000

0.91

3.97

5.4

4.5

1.8

2.2

mu/l

5.29

6325

65455

(3021601) Nitrite [Presence] in Urine by Test strip

4058

38620

1.09

3.93

6.0

4.7

0.0

estimate

0.80

899

7192

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

630

1.53

3.88

1.2

—

71.0

—

(3021788) Differential panel - Synovial fluid

207

1563

1.33

3.84

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

395

3233

1.23

3.84

2.6

3.6

3957.8

1763.7

u/ml

0.46

325

2802

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

152

2.11

3.82

1.3

1.2

0.8

71.5

mg/l

1.00

116

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

633

1.52

3.80

1.2

24.0

42.8

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

221

1.90

3.80

1.5

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

522

1.58

3.79

1.1

1.3

115.1

91.6

u/l

0.87

448

(3036005) Urine sediment comments by Light microscopy Narrative

8.76

3.77

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

142

1014

1.41

3.74

3.9

2.2

4.1

mmol/l

0.08

142

1004

(3035285) Chloride [Moles/volume] in Venous blood

142

1014

1.41

3.74

3.9

2.2

104.4

105.7

mmol/l

1.81

142

1004

(3021387) Prolactin [Units/volume] in Serum or Plasma

224

1725

1.31

3.64

1.5

1.7

361.5

291.6

mu/l

1.88

204

1589

(3025315) Body weight

2.53

3.62

6.6

4.8

—

(3022145) Colonoscopy Study observation

1063

9497

1.13

3.59

1.4

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

314

1.72

3.57

1.9

2.1

6706.8

12983.1

e6/l

0.43

179

(3033705) Calcium.ionized [Moles/volume] in Venous blood

139

999

1.40

3.55

4.0

2.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

270

1.78

3.55

3.1

3.4

57.7

54.1

0.60

259

(4146454)

136

976

1.40

3.51

2.5

2.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

407

1.63

3.51

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

407

1.63

3.51

1.2

1.1

—

(3014891) Appearance of Pleural fluid

2.37

3.47

1.8

1.6

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.34

3.47

1.0

1.1

5467.6

2882.3

ng/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.44

3.37

1.5

2.6

1.2

1.0

mmol/l

0.15

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

174

1.96

3.37

1.1

1.4

—

(3017509) Phencyclidine [Presence] in Urine

2.83

3.35

1.5

1.3

—

(3020491) Glucose [Moles/volume] in Blood

572

1.51

3.32

2.1

1.7

7.6

7.0

mmol/l

0.80

378

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

458

3865

1.19

3.30

1.6

1.7

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

204

1.87

3.28

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

204

1.87

3.28

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

204

1.87

3.28

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

204

1.87

3.28

1.2

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

345

1.66

3.28

1.1

84.0

13.4

u/ml

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

330

1.67

3.27

1.5

1.4

51.8

66.2

2.36

273

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

287

2318

1.25

3.22

2.4

153.0

118.9

ug/min

0.44

173

1412

(3008116) Ketones [Moles/volume] in Urine by Test strip

164

1.95

3.18

1.5

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

391

0.43

3.14

1.2

1.4

—

(3002256) Pathology report gross observation

975

10850

0.89

3.13

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

228

1800

1.27

3.11

5.0

3.0

1.6

mmol/l

0.18

221

1748

(40760888) Immunoglobulin light chains.free panel - Serum

272

2194

1.25

3.10

1.9

3.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

376

1.60

3.04

2.8

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

544

1.49

3.02

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.89

3.02

1.8

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.29

2.99

1.1

1.3

—

(3045424) Erythrocytes [Presence] in Urine

182

1406

1.30

2.96

1.6

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

342

1.61

2.89

3.7

2.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1160

10560

1.11

2.86

4.7

31.9

32.0

0.12

817

7184

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.29

2.83

1.3

1.2

10.8

9.5

mg/l

0.14

(3038515) Glucose [Moles/volume] in Venous blood

214

1701

1.26

2.80

5.2

3.1

7.7

mmol/l

0.03

209

1660

(3002331) Protein [Mass/volume] in Peritoneal fluid

223

1.75

2.80

1.5

1.4

26.2

30.5

g/l

0.27

168

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

127

942

1.35

2.76

2.1

5334.5

3521.2

u/l

0.22

361

(3022621) pH of Urine by Test strip

597

5229

1.15

2.76

3.9

2.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

232

1.73

2.74

1.5

9.6

9.3

ug/l

0.15

232

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

104

2.12

2.74

1.2

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

104

2.12

2.74

1.2

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

104

2.12

2.74

1.2

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

509

1.48

2.70

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

510

1.47

2.68

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

470

1.49

2.66

2.1

1.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

398

1.54

2.65

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

133

1.96

2.64

1.5

10.3

9.9

0.02

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

106

773

1.38

2.59

1.5

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

496

4310

1.16

2.58

1.7

1.8

—

(3049717) Cytology report of Urine Cyto stain

437

3762

1.17

2.57

2.9

2.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

142

1.90

2.54

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

112

827

1.36

2.54

1.3

116015.9

121507.5

e6/l

0.03

576

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

269

1.64

2.52

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

187

1.77

2.48

1.3

1.2

497.6

285.4

pmol/l

0.40

145

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

472

0.55

2.47

1.7

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7860

79786

0.92

2.46

30.3

14.5

26.4

25.5

mg/l

2.02

7221

63482

(3017704) Immunofixation for Urine

479

1.46

2.45

1.3

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

383

1.52

2.41

1.3

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

5.00

2.40

1.8

1.5

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

281

1.60

2.38

1.6

1.4

5.9

2.4

1.07

238

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1136

10440

1.10

2.35

1.5

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

371

0.51

2.31

1.6

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

278

2326

1.20

2.31

1.6

1.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

300

1.57

2.29

2.8

2.9

27.9

28.7

umol/l

0.22

224

(3028717) Thiamine [Mass/volume] in Blood

2.12

2.28

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

285

1.58

2.27

2.4

2.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

530

1.42

2.25

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

530

1.42

2.25

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

531

1.42

2.23

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

163

2036

0.80

2.20

2.1

1.8

194.7

198.7

pmol/l

0.16

151

1908

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

450

1.45

2.18

1.2

1.1

23.5

32.0

u/l

0.75

344

(3047352) Trisomy 18 risk [Likelihood] in Fetus

363

0.52

2.18

1.6

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.34

2.18

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

321

2738

1.18

2.17

1.8

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

451

1.44

2.16

1.2

1.1

93.1

93.7

u/l

0.02

360

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

535

1.40

2.15

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

535

1.40

2.15

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

535

1.40

2.15

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.30

2.14

1.3

1.1

—

(3005033) Fetal Nuchal fold Thickness US

360

0.53

2.13

1.6

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

420

1.46

2.12

1.5

1.6

12.5

11.2

umol/l

0.10

290

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

141

1109

1.28

2.11

1.4

1.6

58.6

59.3

0.08

692

(3030313) Adrenal Ab [Titer] in Serum

2.70

2.10

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

175

1.72

2.08

1.1

—

(4024509)

744

1.33

2.07

1.7

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.90

2.07

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

245

1.59

2.06

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

482

0.60

2.05

3.8

6.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.02

2.05

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

407

1.45

2.04

7.0

10.9

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

169

1.72

2.03

1.1

1.2

—

(40768443) Skin Pathology biopsy report

422

3698

1.15

2.02

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

230

1920

1.20

2.01

1.4

1.3

29.1

33.3

iu/l

1.28

192

1635

(3011325) HIV 1+2 Ab [Presence] in Serum

2.81

2.00

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

255

3011

0.84

1.98

2.3

3.8

50.0

57.9

u/ml

0.28

241

2890

(3019832) Treponema pallidum Ab [Presence] in Serum

403

3528

1.15

1.97

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

371

3229

1.15

1.97

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

125

979

1.28

1.96

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

4.55

1.94

1.0

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

149

1.75

1.94

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

564

1.37

1.92

1.6

1.5

6.8

6.1

u/l

0.14

267

(3010370) Gastrin [Moles/volume] in Serum or Plasma

121

1.82

1.87

1.8

1.7

42.0

48.7

pmol/l

0.24

102

(3047007) Chlamydophila sp Ab [Presence] in Serum

122

960

1.27

1.86

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

260

1.54

1.86

4.8

8.4

—

(3023410) Appearance of Cerebral spinal fluid

741

1.31

1.85

1.8

1.5

—

(40768793) Breast Pathology biopsy report

105

1349

0.78

1.85

1.4

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.03

1.85

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.94

1.84

15.9

8.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

309

1.49

1.84

1.2

2.1

188.0

160.9

1.16

289

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

442

0.61

1.83

1.7

1.4

—

(3016135) IgD [Mass/volume] in Serum

4.17

1.82

1.6

1.0

137.2

36.1

mg/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

206

1.60

1.82

1.1

92.4

85.2

0.51

107

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

441

0.61

1.81

1.7

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.27

1.80

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

440

0.61

1.80

1.7

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

753

1.30

1.80

1.1

—

84.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

2.57

1.80

1.0

1.4

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

3.05

1.79

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

439

0.61

1.79

1.7

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.17

1.77

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.33

1.74

1.5

1.0

3.0

2.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

177

1466

1.21

1.72

4.3

3.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

225

1.56

1.72

4.7

8.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

673

0.70

1.71

1.0

43.6

ng/l

0.00

457

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.06

1.70

1.1

1.0

53.7

8.3

iu/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

236

2012

1.18

1.68

1.5

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

670

0.70

1.67

1.0

839.6

720.3

ng/l

1.12

450

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

203

1.58

1.67

1.1

1.2

89.1

85.6

0.15

109

(3019420) Tryptase [Mass/volume] in Serum or Plasma

375

1.42

1.66

1.3

1.6

9.6

8.9

ug/l

0.10

340

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

2.58

1.65

7.8

5.6

398.0

440.6

umol/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

202

1702

1.19

1.65

5.7

3.3

30.4

28.9

mg/l

0.20

130

1064

(3012494) Peanut IgE Ab [Units/volume] in Serum

157

1.66

1.65

1.1

0.3

1.4

u/ml

0.93

(3045414) Leukocytes [Presence] in Urine

417

3711

1.13

1.64

2.1

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

126

1013

1.25

1.64

2.6

2.3

12.3

2.8

titre

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

667

0.70

1.64

1.0

339.0

324.2

ng/l

0.10

463

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

686

1.30

1.63

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

113

899

1.26

1.61

1.3

59.3

59.5

u/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

369

1.41

1.61

4.6

6.1

68.0

700.3

mg/l

0.51

271

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

152

1.65

1.56

1.1

1.3

79.3

75.0

—

(3044290) Cell count panel - Cerebral spinal fluid

186

1569

1.19

1.53

1.5

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5955

58442

1.05

1.52

4.2

3.8

15.0

14.8

pmol/l

7.87

5334

52805

(40758292) HTLV I+II Ab panel - Serum

141

0.43

1.51

1.0

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

169

1.60

1.51

1.1

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.59

1.51

1.0

1.3

—

mmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

138

1.67

1.51

1.8

1.7

—

(3007916) DNA double strand Ab [Titer] in Serum

1.83

1.51

1.2

1.3

—

110.3

—

(40768804) Tissue Pathology biopsy report

3151

32568

0.95

1.51

2.2

2.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

227

1950

1.17

1.50

1.3

522.6

558.7

mg/l

0.63

210

1847

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.86

1.50

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

860

0.75

1.49

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

479

1.34

1.46

1.4

1.5

5.6

6.2

u/l

0.62

414

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.37

1.45

1.3

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

394

1.37

1.45

1.1

8.4

10.6

iu/ml

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

3.13

1.44

1.0

0.0

0.2

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

1780

16976

1.06

1.43

5.1

4.0

1.0

kg/l

0.45

294

2505

(3013293) Extractable nuclear Ab [Presence] in Serum

110

1.73

1.42

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

578

1.30

1.41

1.5

2.0

17.1

nmol/l

0.00

545

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.82

1.41

1.0

1.1

—

(4027681)

388

1.37

1.40

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.25

1.40

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

212

0.52

1.39

1.0

1.3

—

(40761535) Cells panel - Urine sediment

749

6944

1.09

1.37

3.7

3.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

231

1.47

1.36

2.0

2.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

112

1.70

1.35

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

151

1.59

1.34

1.1

1.2

105.6

79.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.04

1.32

1.4

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.04

1.32

1.2

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

146

0.48

1.31

1.6

3.2

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

2.35

1.29

7.8

5.2

18.7

16.5

mmol/l

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

185

1.51

1.28

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

114

1.67

1.28

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

217

1888

1.15

1.27

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

598

1.27

1.25

1.4

1.3

2.2

2.1

mmol/l

0.08

563

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

529

0.72

1.25

1.1

1.3

1.5

1.4

g/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.22

1.24

1.4

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

511

1.29

1.24

1.2

1.1

393.3

298.8

mg/l

0.37

443

(3006462) Nitrate [Presence] in Urine

389

1.34

1.23

3.3

3.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

195

1.49

1.23

1.9

2.4

7.5

7.9

mmol/l

0.19

111

(4034850)

239

2715

0.88

1.23

17.6

10.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

652

0.75

1.22

2.7

5.3

53.0

63.1

u/ml

0.15

189

(3000012) Reticulocyte production index

495

1.29

1.21

1.2

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.80

1.20

1.1

1.2

95.2

118.8

ug/l

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

176

1515

1.16

1.20

1.2

1.3

141.8

214.2

miu/ml

1.48

610

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

222

1.44

1.18

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

1039

0.81

1.18

1.3

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.70

1.17

2.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.50

1.15

1.0

2.3

—

(3036603) Volume of Urine

571

1.26

1.14

1.6

1.7

1699.9

2021.7

0.96

141

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.85

1.13

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.33

1.12

1.0

1.1

—

(3013762) Body weight Measured

2.33

1.12

1.0

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

139

1629

0.85

1.12

1.3

1.5

—

(3048879) Bone marrow aspiration report

251

1.40

1.10

1.2

1.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2161

22377

0.96

1.10

1.7

1.6

1.4

mmol/l

14.63

1818

18576

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

2.38

1.09

1.0

2.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.95

1.08

10.3

9.5

—

(3016018) Differential panel - Cerebral spinal fluid

100

828

1.21

1.08

1.6

1.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

1.3

0.3

u/ml

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

196

1718

1.14

1.07

1.2

1.3

4.0

3.9

mmol/l

0.88

176

1615

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

754

7072

1.07

3.8

2.6

62.5

65.4

ml/min/173m2

0.97

331

2762

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.71

1.05

1.1

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

204

1.42

1.02

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

114

1.58

1.02

1.6

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

210

1858

1.13

1.01

1.1

17.0

6.7

u/ml

0.33

212

(1617658) Protocol used for examination of sentinel lymph nodes

485

0.74

1.01

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

195

1718

1.14

1.01

1.5

1.4

13.0

25.0

e6/l

1.01

152

1309

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

195

1719

1.14

1.00

1.6

1.4

1610.1

1436.8

e6/l

0.09

158

1384

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.77

1.00

1.0

0.0

1.5

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

431

1.28

0.99

1.3

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

895

8468

1.06

0.99

1.6

1.5

—

(3024263) Appearance of Synovial fluid

476

1.26

0.98

1.7

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.17

0.98

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.17

0.98

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2124

20551

1.04

0.97

4.4

3.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.67

0.97

2.5

2.1

57.5

58.5

—

(3015183) Erythrocyte sedimentation rate

331

0.69

0.97

1.4

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.63

0.97

2.2

2.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

531

1.24

0.96

1.3

1.2

72.5

44.0

mg/l

0.41

446

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

549

1.24

0.96

1.4

15.5

13.3

umol/l

1.08

517

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.80

0.96

1.1

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

190

1.42

0.96

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

199

1.41

0.95

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

502

5400

0.93

0.95

2.4

22.8

24.6

au/ml

0.10

245

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

191

1.41

0.94

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.61

0.93

1.1

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.22

0.93

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

200

1.40

0.93

1.2

1.1

—

(3016750) Collection duration of Urine

543

1.24

0.93

2.2

486.3

492.8

min

0.20

405

(4211845)

427

1.27

0.92

3.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

210

1.38

0.90

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.38

0.90

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

519

0.77

0.89

1.8

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

474

1.25

0.89

1.0

1.1

8.6

9.0

nmol/l

0.02

108

(3008898) HLA-B27 [Presence]

190

2134

0.89

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

271

1.33

0.88

1.3

1.2

39.6

39.9

g/l

0.04

147

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

421

1.26

0.88

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

421

1.26

0.88

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

133

1526

0.87

1.7

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

360

1.28

0.86

1.3

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

136

1.47

0.86

4.9

4.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

178

1.41

0.86

4.4

7.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

1.67

0.85

1.0

1.4

6.4

19.5

pmol/l

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.78

0.84

1.1

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.78

0.84

3.5

3.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.70

0.80

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

181

1.38

0.79

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

356

1.27

0.79

2.8

2.2

53.4

55.1

umol/l

0.15

289

(3036525) Urea [Moles/time] in 24 hour Urine

1.72

0.79

2.4

3.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.82

0.79

1.5

1.4

60.2

15.0

nmol/l

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

122

0.57

0.77

4.9

9.2

0.2

0.3

umol/l

—

116

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.77

0.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

174

1.38

0.76

1.3

79.5

70.5

mu/l

0.10

131

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

332

1.27

0.75

1.1

—

(44806071)

1.52

0.75

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.08

0.74

1.2

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.67

0.74

1.6

1.4

516.1

333.7

umol/24h

—

(40768446) Kidney Pathology biopsy report

360

1.25

0.74

1.6

1.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

108

0.56

0.72

1.2

1.1

115.4

61.0

u/ml

—

103

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.62

0.71

1.3

1.1

4.2

13.3

u/l

1.41

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

471

4434

1.07

0.68

2.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.54

0.67

5.6

5.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.54

0.67

2.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

223

1.30

0.66

1.2

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.61

0.65

1.2

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

103

1.46

0.64

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1019

0.87

0.62

1.4

1.2

7.7

7.6

mmol/l

0.11

751

(3009015) Lactate [Moles/volume] in Synovial fluid

104

1.44

0.62

1.1

1.3

5.5

6.7

mmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

198

1810

1.10

0.62

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

599

1.17

0.62

1.2

11.7

11.8

mmol/l

0.03

182

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.55

0.62

3.0

5.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

226

1.28

0.61

1.2

1.3

109.4

140.7

nmol/l

0.48

167

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.60

0.61

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

390

0.79

0.60

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

361

3386

1.07

0.60

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.57

0.60

3.0

5.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.57

0.60

1.1

1.0

—

(40762814) Titanium [Mass/volume] in Blood

165

1.33

0.60

2.6

2.4

3.7

3.9

ug/l

—

(3025130) Human papilloma virus identified in Specimen

630

1.16

0.59

1.8

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

208

1912

1.09

0.59

3.0

3.6

121.3

741.3

u/ml

3.04

182

1761

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

482

1.18

0.59

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

465

4910

0.94

0.58

1.3

40.4

52.6

au/ml

0.89

218

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.58

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

282

1.24

0.57

1.7

1.4

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.71

0.57

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

829

1.14

0.57

1.4

1.5

25.1

28.8

0.48

511

(3020961) Endomysium IgA Ab [Titer] in Serum

340

3192

1.07

0.56

1.1

300.5

253.4

titre

0.15

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.67

0.56

1.2

1.1

189.0

263.3

nmol/l

—

(40760410) HLA-B [Type] by High resolution

1.67

0.56

1.0

—

(40763590) HLA-DQ beta [Type]

1.67

0.56

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.67

0.56

1.3

1.5

—

(40760409) HLA-A [Type] by High resolution

1.67

0.56

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.67

0.56

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

811

1.14

0.56

1.8

1.9

1.2

1.0

g/24h

—

(40765096) Chromosome analysis panel by Banding

286

0.77

0.56

1.1

—

(4212803)

0.56

0.55

1.2

1.1

—

(3013862) HLA-DP [Type]

1.62

0.55

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.58

0.54

3.0

14.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.50

0.54

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

459

0.83

0.53

1.2

1.8

—

(4281824)

801

0.87

0.52

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

100

0.60

0.51

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

107

960

1.12

0.51

1.7

2.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

180

0.72

0.51

1.6

5.1

30.7

45.2

u/l

—

(3037556) Urate [Mass/volume] in Serum or Plasma

289

1.21

0.48

1.7

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

456

1.16

0.47

1.7

1.9

2.6

2.9

u/field

0.11

322

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

382

1.18

0.47

1.3

1.2

39.6

62.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

102

1.37

0.47

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

202

1879

1.08

0.46

2.6

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.38

0.45

1.3

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.61

0.45

1.2

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

153

0.72

0.45

6.1

6.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

927

0.89

0.44

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

563

1.14

0.44

1.7

1.6

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

148

1.28

0.43

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

212

1.23

0.42

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.35

0.41

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.35

0.41

1.1

1.3

30.1

30.9

nmol/l

—

(21494814) CD8 cells/100 lymphocytes in Specimen

332

1.18

0.41

1.5

2.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.52

0.41

1.4

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.41

0.0

3.3

—

1.6

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

261

0.80

0.41

1.3

1.2

44.7

22.3

—

(3004775) Volume in Urine collected for unspecified duration

787

1.11

0.39

2.5

2.3

641.2

677.3

0.32

531

(3013166) Neutrophils/100 leukocytes in Synovial fluid

269

1.19

0.39

1.3

59.3

55.1

0.24

226

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

105

0.67

0.39

1.3

1.1

—

(3012565) Volume of 24 hour Urine

447

1.14

0.38

2.0

2.3

2060.3

1895.3

0.23

388

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

124

1.29

0.38

1.2

1.4

42.3

56.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.36

0.38

2.7

2.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

429

1.14

0.38

1.3

1.5

3.5

3.4

—

101

(1761482) Bacteria [#/volume] in Urine by Culture

204

2168

0.94

0.38

5.4

3.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

192

0.78

0.37

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.35

0.37

1.3

1.4

—

(3001729) Color of Synovial fluid

1.39

0.36

1.2

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

375

0.85

0.36

1.2

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

384

1.15

0.36

1.1

1.0

1.1

u/l

2.53

183

(1002224) Polysomnography panel

301

3156

0.95

0.35

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.33

0.35

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.63

0.35

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

963

0.91

0.35

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

246

1.18

0.34

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

688

0.90

0.33

1.2

366.1

362.8

nmol/l

0.04

570

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

177

0.79

0.33

1.8

2.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.35

0.31

1.7

1.3

1.4

umol/l

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.30

0.30

1.1

1.6

5.1

13.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

962

0.92

0.29

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

260

0.85

0.29

1.2

1.6

3.0

4.4

ug/l

0.44

193

(3020874) Milk IgE Ab [Units/volume] in Serum

316

1.14

0.29

1.1

1.0

1.4

1.0

u/ml

0.24

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

449

1.11

0.29

9.0

5.7

108.4

575.2

u/ml

0.67

(3032868) Hemoglobin electrophoresis panel in Blood

1.29

0.28

1.3

1.5

—

(3016228) CD19 cells/100 cells in Blood

346

1.13

0.27

1.6

2.0

7.3

8.3

0.33

332

(44806420)

233

1.16

0.27

2.1

2.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

657

0.91

0.27

1.4

0.2

nmol/l

0.33

473

(3020650) Glucose [Presence] in Urine

196

1.17

0.27

1.3

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

309

1.13

0.26

1.1

1401.5

1541.6

miu/ml

0.36

309

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.68

0.26

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

158

1501

1.05

0.25

1.7

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.18

0.24

1.1

1.2

2.0

1.8

umol/24h

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

283

1.13

0.24

1.7

1.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.73

0.24

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

195

1866

1.05

0.24

1.8

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.71

0.24

1.2

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

349

0.89

0.23

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

190

0.84

0.23

8.0

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

147

0.82

0.23

1.5

1.6

4.3

2.2

ug/l

—

(40768795) Lymph node Pathology biopsy report

867

0.93

0.23

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.25

0.22

1.4

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.4

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.21

0.0

2.0

—

16.7

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.21

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

306

1.11

0.20

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

355

1.10

0.20

1.7

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.20

0.19

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

336

1.10

0.19

1.3

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

908

1.06

0.19

1.1

3.5

3.4

u/ml

0.07

394

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

174

1.15

0.19

1.5

9.9

8.8

mmol/l

0.67

(3020393) Adenovirus Ag [Presence] in Stool

1.23

0.18

1.0

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.19

0.18

1.1

1.6

52.7

32.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

163

0.86

0.17

1.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

110

1.18

0.17

1.3

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

140

1457

0.96

0.17

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

0.75

0.17

1.4

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.72

0.16

1.8

4.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.18

0.16

1.0

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

495

1.07

0.16

1.5

1.2

—

(21494434) Karyotype in Bone marrow

768

1.06

0.16

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

297

0.91

0.15

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.15

0.15

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

488

1.07

0.14

1.5

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.08

0.14

1.4

1.9

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.08

0.14

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

112

1.16

0.14

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

131

1.15

0.14

4.8

5.6

31.4

55.6

ug/min

—

108

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

122

1.15

0.13

1.1

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.82

0.13

2.4

2.8

0.4

u/field

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

422

1.07

0.13

1.2

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

258

1.09

0.12

1.1

1.0

0.6

2.5

u/ml

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

231

2265

1.02

0.10

2.2

1.7

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

1.11

0.09

1.2

1.5

2.4

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.04

0.09

1.8

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.09

0.08

1.7

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.82

0.08

2.4

2.7

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.81

0.08

1.0

5.4

72.4

69.0

g/mol

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2999

29884

1.01

0.08

4.9

3.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

653

0.96

0.08

2.2

2.0

1.5

1.6

u/field

0.11

285

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

127

1.10

0.07

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.86

0.07

1.0

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.12

0.07

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

225

1.07

0.07

1.5

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

0.89

0.06

3.9

2.6

344.1

303.2

umol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

101

0.89

0.06

1.6

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

217

1.06

0.06

2.7

5.6

65.0

69.6

0.24

175

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

287

1.05

0.05

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

110

1.09

0.05

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

115

1168

0.98

0.04

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

418

4205

0.99

0.03

4.3

3.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

161

1.06

0.03

2.2

1.6

—

65.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

631

0.98

0.02

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

279

0.97

0.02

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

212

1.04

0.02

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1064

10660

1.00

0.02

10.0

7.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

427

4282

1.00

0.01

1.2

123.8

138.1

iu/ml

0.30

125

1584

(3014599) Egg white IgE Ab [Units/volume] in Serum

303

1.02

0.01

1.1

1.0

6.9

0.5

u/ml

0.48

(3013139) Helicobacter pylori Ag [Presence] in Stool

506

5068

1.00

0.00

1.3

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

394

1.02

0.00

1.6

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

216

1.02

0.00

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

244

0.98

0.00

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

175

0.97

0.00

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

225

0.98

0.00

1.8

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

325

1.02

0.00

1.2

1.1

119.6

437.8

ng/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

122

0.98

0.00

1.0

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

179

1.01

0.00

1.1

1.3

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.01

0.00

1.0

2.2

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

19.3

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.96

0.00

1.3

—

502.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.95

0.00

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.5

—

11.6

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint COPD_EARLY and mortality.

Females

Parameter	HR [95% CI]	p-value
COPD_EARLY	5.788 [5.33, 6.28]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 5790 out of 19608 females with COPD_EARLY died.

Males

Parameter	HR [95% CI]	p-value
COPD_EARLY	4.076 [3.78, 4.4]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 14125 out of 35925 males with COPD_EARLY died.

Mortality risk

Mortality risk for people of age

years, who have COPD_EARLY.

N-year risk	Females	Males
1	0.467%	0.687%
5	2.872%	4.076%
10	6.558%	10.345%
15	12.484%	19.555%
20	21.139%	31.398%

Relationships between endpoints

↥

Index endpoint: COPD_EARLY – Early onset COPD

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Early onset COPD

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints